- tyrosine aminotransferase
- agammaglobulinemia tyrosine kinase
- protein-tyrosine-phosphatase
- trkb tyrosine kinase
- tubulin--tyrosine ligase
- tyrosine 3-hydroxylase
- tyrosine kinase epha3
- tyrosine kinase epha6
- tyrosine kinase ephb3
- tyrosine kinase receptor a
- tyrosine-protein kinase
- protein tyrosine phosphatase ptpb
- protein-tyrosine kinase cyl
- protein-tyrosine phosphatase 1d
- protein-tyrosine phosphatase alpha
- receptor protein-tyrosine kinase
- secreted protein-tyrosine phosphatase
- spleen tyrosine kinase (syk)
- tyrosine kinase receptor (trk)
- tyrosine kinase receptor a (trk-a)
- tyrosine kinase zap-70
- tyrosine-protein kinase (abl)
- tyrosine-protein kinase (btk)
- tyrosine-protein kinase 6
- tyrosine-protein kinase abl1
- tyrosine-protein kinase abl2
- tyrosine-protein kinase blk
- tyrosine-protein kinase btk
- tyrosine-protein kinase csk
- tyrosine-protein kinase ctk
- tyrosine-protein kinase fer
- tyrosine-protein kinase fes
- tyrosine-protein kinase fgr
- tyrosine-protein kinase fyn
- tyrosine-protein kinase jak1
- tyrosine-protein kinase jak2
- tyrosine-protein kinase jak3
- tyrosine-protein kinase kit
- tyrosine-protein kinase lck
- tyrosine-protein kinase lyn
- tyrosine-protein kinase mer
- tyrosine-protein kinase pkm2
- tyrosine-protein kinase receptor
- tyrosine-protein kinase sgk269
- tyrosine-protein kinase sky
- tyrosine-protein kinase src
- tyrosine-protein kinase syk
- tyrosine-protein kinase tec
- tyrosine-protein kinase txk
- tyrosine-protein kinase tyk2
- tyrosine-protein kinase tyro4
- tyrosine-specific protein kinase
- epidermal growth factor receptor/receptor tyrosine-protein kinase erbb-2/receptor tyrosine-protein kinase erbb-3/receptor tyrosine-protein kinase erbb-4
- alk tyrosine kinase receptor (alk)
- alk tyrosine kinase receptor (f1174l)
- alk tyrosine kinase receptor (r1275q)
- alk tyrosine kinase receptor [c1156y]
- alk tyrosine kinase receptor [g1202r]
- alk tyrosine kinase receptor [g1269s]
- axl receptor tyrosine kinase ligand
- erbb-4 (her4) tyrosine kinase
- gst-tyrosine-protein kinase syk
- hematopoietic cell protein-tyrosine phosphatase
- hematopoietic protein-tyrosine phosphatase (heptp)
- met proto-oncogene tyrosine kinase
- nuclear tyrosine protein kinase rak
- protein tyrosine phosphatase (ptp) shp2
- protein tyrosine phosphatase 1b (ptp1b)
- protein-tyrosine phosphatase 1b (ptp1b)
- protein-tyrosine phosphatase mitochondrial 1
- stem cell tyrosine kinase 1
- trk1-transforming tyrosine kinase protein
- tyrosine kinase flt3 mutant (d835h)
- tyrosine kinase flt3 mutant (d835y)
- tyrosine-protein kinase abl (t315i)
- tyrosine-protein kinase abl (y253h)
- tyrosine-protein kinase abl1 (abl)
- tyrosine-protein kinase abl1 (abl1)
- tyrosine-protein kinase abl1 [h396p]
- tyrosine-protein kinase abl1/abl2
- tyrosine-protein kinase blk (blk)
- tyrosine-protein kinase bmx/etk
- tyrosine-protein kinase btk (c481s)
- tyrosine-protein kinase btk/fyn
- tyrosine-protein kinase btk/lck
- tyrosine-protein kinase fyn (y531f)
- tyrosine-protein kinase itk (itk)
- tyrosine-protein kinase jak1 (jak1)
- tyrosine-protein kinase jak1/jak2
- tyrosine-protein kinase jak1/jak3
- tyrosine-protein kinase jak2 [v617f]
- tyrosine-protein kinase met (cmet)
- tyrosine-protein kinase receptor [l1196m]
- tyrosine-protein kinase receptor eek
- tyrosine-protein kinase receptor eph
- tyrosine-protein kinase receptor flt
- tyrosine-protein kinase receptor ros
- tyrosine-protein kinase receptor ufo
- tyrosine-protein kinase src (f278h)
- tyrosine-protein kinase syk (syk)
- vhl/tyrosine-protein kinase abl2
- interferon alpha-1/13/tyrosine-protein kinase jak1/non-receptor tyrosine-protein kinase tyk2
- alk tyrosine kinase receptor (alk) (c1156y)
- developmentally-regulated eph-related tyrosine kinase
- egf-r tyrosine kinase mutant (g719s)
- egf-r tyrosine kinase mutant (l858r)
- egf-r tyrosine kinase mutant (t790m)
- interlukin-2-inducible tyrosine kinase (itk)
- janus kinase 2 (a protein tyrosine kinase)
- megakaryocyte protein-tyrosine phosphatase (ptp-meg2)
- non-receptor tyrosine-protein kinase tnk1
- non-receptor tyrosine-protein kinase tyk2
- non-specific protein-tyrosine kinase [t818i]
- protein cereblon/tyrosine-protein kinase src
- protein nef/tyrosine-protein kinase hck
- protein-tyrosine kinase receptor flk-1
- proto-oncogene tyrosine-protein kinase abl1
- proto-oncogene tyrosine-protein kinase mer
- proto-oncogene tyrosine-protein kinase ros
- proto-oncogene tyrosine-protein kinase src
- receptor protein-tyrosine kinase erbb-2
- receptor tyrosine-protein kinase erbb-1
- receptor tyrosine-protein kinase erbb-2
- receptor-type tyrosine-protein kinase flt3
- receptor-type tyrosine-protein phosphatase epsilon
- ret proto-oncogene tyrosine kinase receptor
- tubulin--tyrosine ligase-like protein 7
- tyrosine kinase c-kit mutant (n822k)
- tyrosine kinase c-kit mutant (v559d)
- tyrosine kinase c-met mutant (d1228h)
- tyrosine kinase c-met mutant (y1230h)
- tyrosine- and threonine-specific cdc2-inhibitory kinase
- tyrosine-protein kinase abl1 [201-500]
- tyrosine-protein kinase abl1 [229-512]
- tyrosine-protein kinase btk (386-659)
- tyrosine-protein kinase btk [14-552]
- tyrosine-protein kinase btk [328-659]
- tyrosine-protein kinase btk [389-659]
- tyrosine-protein kinase btk [393-659]
- tyrosine-protein kinase fyn isoform b
- tyrosine-protein kinase jak1 (850-1154)
- tyrosine-protein kinase jak1 [574-1154]
- tyrosine-protein kinase jak1 [850-1154]
- tyrosine-protein kinase jak1 [852-1142]
- tyrosine-protein kinase jak2 (808-1132)
- tyrosine-protein kinase jak2 (826-1132)
- tyrosine-protein kinase jak2 (y1007f, y1008f)
- tyrosine-protein kinase jak2 [532-1132]
- tyrosine-protein kinase jak2 [808-1132]
- tyrosine-protein kinase jak2 [809-1153]
- tyrosine-protein kinase jak2 [828-1132]
- tyrosine-protein kinase jak2 [866-1054]
- tyrosine-protein kinase jak3 (781-1124)
- tyrosine-protein kinase jak3 [1-973]
- tyrosine-protein kinase jak3 [795-1124]
- tyrosine-protein kinase jak3 [811-1124]
- tyrosine-protein kinase lck [245-498]
- tyrosine-protein kinase mer [557-882]
- tyrosine-protein kinase receptor mpk-5
- tyrosine-protein kinase syk [2-635]
- tyrosine-protein kinase syk [355-635]
- tyrosine-protein kinase transforming protein abl
- tyrosine-protein kinase transforming protein src ITC
- dimer of receptor-type tyrosine-protein kinase flt3
- dual specificity tyrosine-phosphorylation-regulated kinase 1a
- dual specificity tyrosine-phosphorylation-regulated kinase 1b
- dual specificity tyrosine-phosphorylation-regulated kinase 2
- dual-specificity tyrosine-phosphorylation regulated kinase 1a
- inactive tyrosine-protein kinase transmembrane receptor ror1
- neuronal proto-oncogene tyrosine-protein kinase src
- non-receptor tyrosine-protein kinase tyk2 (tyk2)
- npm/alk (nucleophosmin/alk tyrosine kinase receptor)
- protein tyrosine phosphatase shp-1 (shp-1)
- protein-tyrosine phosphatase 1b (ptp1b) mutant (g117e)
- protein-tyrosine phosphatase 1b (ptp1b) mutant (l119v)
- protein-tyrosine phosphatase 1b (ptp1b) mutant (m114v)
- proto-oncogene tyrosine-protein kinase receptor ret
- proto-oncogene tyrosine-protein kinase ros (g2032r)
- proto-oncogene tyrosine-protein kinase ros [d2033n]
- proto-oncogene tyrosine-protein kinase ros [l2026m]
- proto-oncogene tyrosine-protein kinase src [s345c]
- proto-oncogene tyrosine-protein kinase src [t341m]
- ptk2b protein tyrosine kinase 2 beta (ptk2b)
- receptor-type tyrosine-protein kinase flt3 (n841i)
- receptor-type tyrosine-protein kinase flt3 (r834q)
- receptor-type tyrosine-protein kinase flt3 [d835v]
- receptor-type tyrosine-protein kinase flt3 [k663q]
- receptor-type tyrosine-protein phosphatase c (cd45)
- tyrosine kinase c-kit mutant (v559d/t670i)
- tyrosine-protein kinase abl1 [1-999,e255k]
- tyrosine-protein kinase abl1 [1-999,e255v]
- tyrosine-protein kinase abl1 [1-999,q252h]
- tyrosine-protein kinase abl1 [201-500,e255k]
- tyrosine-protein kinase abl1 [201-500,h396p]
- tyrosine-protein kinase jak1 (aa 866-1154)
- tyrosine-protein kinase jak2 jh1 (808-1132)
- tyrosine-protein kinase kit (kit)(v560g/d816v)
- tyrosine-protein kinase receptor ufo (h473-a894)
- tyrosine-protein phosphatase non-receptor type 1
- tyrosine-protein phosphatase non-receptor type 11
- tyrosine-protein phosphatase non-receptor type 14
- tyrosine-protein phosphatase non-receptor type 21
- abelson tyrosine-kinase 1 sh2 domain (abl sh2)
- abelson tyrosine-kinase 2 sh2 domain (arg sh2)
- breakpoint cluster region protein/tyrosine-protein kinase abl1
- dimer of receptor-type tyrosine-protein kinase flt3 [d835v]
- dimer of receptor-type tyrosine-protein kinase flt3 [f691l]
- non-receptor tyrosine-protein kinase tyk2 (871-1187)
- non-receptor tyrosine-protein kinase tyk2 [5-1181]
- non-receptor tyrosine-protein kinase tyk2 [556-871]
- non-receptor tyrosine-protein kinase tyk2 [580-1182]
- non-receptor tyrosine-protein kinase tyk2 [833-1187]
- non-receptor tyrosine-protein kinase tyk2 [870-1187]
- non-receptor tyrosine-protein kinase tyk2 [886-1187]
- non-receptor tyrosine-protein kinase tyk2 [888-1187]
- protein-tyrosine phosphatase 1b (ptp1b) mutant (v113l/m114v)
- proto-oncogene tyrosine-protein kinase abl1 mutant f359v
- proto-oncogene tyrosine-protein kinase abl1 mutant t315i
- proto-oncogene tyrosine-protein kinase receptor ret (g810r)
- proto-oncogene tyrosine-protein kinase receptor ret (v804m)
- proto-oncogene tyrosine-protein kinase receptor ret [g810r]
- proto-oncogene tyrosine-protein kinase receptor ret [g810s]
- proto-oncogene tyrosine-protein kinase receptor ret [m918t]
- proto-oncogene tyrosine-protein kinase src (c-src)
- proto-oncogene tyrosine-protein kinase src (t338c/v323s)
- proto-oncogene tyrosine-protein kinase src [251-533]
- receptor-type tyrosine-protein kinase flt3 [564-993]
- t-cell protein-tyrosine phosphatase (tcptp) mutant (v121l)
- tyrosine kinase csf1-r mutant (tie2 kid chimera)
- tyrosine-protein kinase jak2 jh2 (536-812) v617f
- tyrosine-protein kinase jak2 jh2 wt (536-812)
- tyrosine-protein kinase mer [557-882,h628q,r794a]
- tyrosine-protein kinase receptor ufo (473-894)(q764r)
- tyrosine-protein phosphatase non-receptor type 1 (ptp1b)
- tyrosine-protein phosphatase non-receptor type 1 [v113i]
- tyrosine-protein phosphatase non-receptor type 11 [e76k]
- tyrosine-protein phosphatase non-receptor type 11 [e76z]
- dual specificity tyrosine-phosphorylation-regulated kinase 2 [393-601]
- isoform 2 of proto-oncogene tyrosine-protein kinase receptor ret
- kinesin-1 heavy chain/ tyrosine-protein kinase receptor ret
- non-receptor tyrosine-protein kinase tyk2 (aa 556-888)
- non-receptor tyrosine-protein kinase tyk2 (aa 575-869)
- protein-glutamine gamma-glutamyltransferase 2/tyrosine-protein kinase jak3
- proto-oncogene tyrosine-protein kinase receptor ret (658-end)
- proto-oncogene tyrosine-protein kinase receptor ret [638-1114]
- proto-oncogene tyrosine-protein kinase src (aa 1-530)
- proto-oncogene tyrosine-protein kinase src (aa 145-252)
- proto-oncogene tyrosine-protein kinase src [251-533,t338c]
- receptor protein-tyrosine kinase/serine/threonine-protein kinase mtor
- receptor-type tyrosine-protein kinase flt3 [563-993,d835y]
- receptor-type tyrosine-protein kinase flt3 [564-710,762-958]
- tyrosine-protein kinase abl1 [t315i]/breakpoint cluster region protein
- tyrosine-protein phosphatase non-receptor type 1 [1-298]
- tyrosine-protein phosphatase non-receptor type 1 [1-301]
- tyrosine-protein phosphatase non-receptor type 1 [1-321]
- tyrosine-protein phosphatase non-receptor type 1 [1-322]
- tyrosine-protein phosphatase non-receptor type 1 [1-405]
- tyrosine-protein phosphatase non-receptor type 11 (ptpn11)(e76k)
- tyrosine-protein phosphatase non-receptor type 11 [205-593]
- tyrosine-protein phosphatase non-receptor type 2 (tc-ptp)
- tyrosine-protein phosphatase non-receptor type 22 [1-303]
- tyrosine-protein phosphatase non-receptor type 9 (ptp-meg2)
- dna-dependent protein kinase catalytic subunit/tyrosine-protein kinase abl1
- epidermal growth factor receptor/receptor tyrosine-protein kinase erbb-2
- proto-oncogene tyrosine-protein kinase receptor ret [658-1114,g810r]
- proto-oncogene tyrosine-protein kinase src [251-533,v323a,t338c]
- coiled-coil domain-containing protein 6/tyrosine-protein kinase receptor ret
- hepatocyte growth factor receptor/proto-oncogene tyrosine-protein kinase receptor ret
- protein-glutamine gamma-glutamyltransferase 2/receptor-type tyrosine-protein phosphatase eta
- proto-oncogene tyrosine-protein kinase src/serine/threonine-protein kinase mtor
- syk rpa purified, truncated construct of spleen tyrosine kinase (aa 360-635)
L-Tyrosine, 24 BDBM92702
BDBM36038 N-acetyl-L-tyrosine
N-Chloroacetyl-L-tyrosine BDBM93101
N-acetyl-D-tyrosine BDBM36037
D-Tyrosine BDBM50463198 CHEBI:28479 CHEMBL1076637
BDBM50336338 CHEMBL1667956 Triazole tetra-benzyloxy-beta-D-O-glucosyl Tyrosine
CHEMBL1667960 Triazole tetra-benzyloxy-beta-D-O-galactosyl Tyrosine BDBM50336332
- Goldstein, DM Tyrosine kinase inhibitors US Patent US9090621 (2015)
- Guo, X; Zhu, Z Compounds as tyrosine kinase modulators US Patent US9725433 (2017)
- Heymach, J; Robichaux, J; Nilsson, M; Jones, P; Cross, J; Theroff, J Heterocyclic inhibitors of tyrosine kinase US Patent US11365189 (2022)
- Zhang, Z; Zhang, S Inhibitors of protein tyrosine phosphatases US Patent US9217012 (2015)
- Goldstein, DM; Brameld, KA; Verner, E Azaindole derivatives as tyrosine kinase inhibitors US Patent US9187487 (2015)
- Goldstein, DM; Owens, TD Heterocycle comprising tyrosine kinase inhibitors US Patent US11155544 (2021)
- Mahajan, NP; Mahajan, KN; Lawrence, NJ; Lawrence, HR Inhibitors of ACK1/TNK2 tyrosine kinase US Patent US10336734 (2019)
- Sun, F; Zhan, Y Tyrosine kinase inhibitor and application thereof US Patent US10882853 (2021)
- Wu, F Tyrosine kinase inhibitor and uses thereof US Patent US10300058 (2019)
- Roller, PP; Wu, L; Zhang, ZY; Burke, TR Potent inhibition of protein-tyrosine phosphatase-1B using the phosphotyrosyl mimetic fluoro-O-malonyl tyrosine (FOMT). Bioorg Med Chem Lett 8: 2149-50 (1999)
- Comeau, AB; Critton, DA; Page, R; Seto, CT A focused library of protein tyrosine phosphatase inhibitors. J Med Chem 53: 6768-72 (2010)
- Liao, X; Li, J; Lu, Z; Zhou, Y; Gao, A Bruton's tyrosine kinase inhibitors US Patent US11554118 (2023)
- Chin, YW; Kong, JY; Han, SY Flavonoids as receptor tyrosine kinase FLT3 inhibitors. Bioorg Med Chem Lett 23: 1768-70 (2013)
- Argiriadi, MA; Breinlinger, EC; Chien, EY; Cowart, MD; Frank, KE; Friedman, MM; Hardee, DJ; Herold, JM; Liu, H; Qiu, W; Scanio, MJ; Schrimpf, MR; Vargo, TR; Van Epps, SA; Webster, MP; Little, AJ; Katcher, MH INHIBITORS OF TYROSINE KINASE 2 MEDIATED SIGNALING US Patent US20190276450 (2019)
- Berdini, V; Carr, MG; Congreve, MS; Frederickson, M; Griffiths-Jones, CM; Hamlett, CC; Madin, A; Murray, CW; Benning, RK; Saxty, G; Vickerstaffe, E; Williams, BJ; Woodhead, AJ; Woodhead, SJ; Freyne, EJ; Govaerts, TC; Angibaud, PR Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases US Patent US8796244 (2014)
- Han, Y; Zhu, L; Xiao, D; Peng, Y; Luo, H Inhibitor of bruton's tyrosine kinase US Patent US10112922 (2018)
- De Vicente Fidalgo, J; Dominique, R; Lopez-Tapia, FJ; So, S Inhibitors of Bruton's tyrosine kinase US Patent US9469644 (2016)
- Dewdney, NJ; Lou, Y; Sjogren, EB; Soth, M; Sweeney, ZK Inhibitors of Burton's tyrosine kinase US Patent US8536166 (2013)
- Lopez-Tapia, FJ Inhibitors of bruton's tyrosine kinase US Patent US9663494 (2017)
- Zhang, Z; Lin, J Lymphoid-specific tyrosine phosphatase (LYP) inhibitors US Patent US11629130 (2023)
- Lee, KI; Park, Y; Park, SJ; Hwang, JH; Lee, SJ; Kim, GD; Park, WK; Lee, S; Jeong, D; Kong, JY; Kang, HK; Cho, H Naphthofuroquinone derivatives: inhibition of receptor tyrosine kinases. Bioorg Med Chem Lett 16: 737-42 (2005)
- Yin, B; Fang, DM; Zhou, XL; Gao, F Natural products as important tyrosine kinase inhibitors. Eur J Med Chem 182: (2019)
- Hu, S; Liu, X; Bai, J; Long, W Protein tyrosine kinase modulators and methods of use US Patent US9783524 (2017)
- Padilla, F; Bhagirath, N; Chen, S; Chiao, E; Goldstein, DM; Hermann, JC; Hsu, J; Kennedy-Smith, JJ; Kuglstatter, A; Liao, C; Liu, W; Lowrie, LE; Luk, KC; Lynch, SM; Menke, J; Niu, L; Owens, TD; O-Yang, C; Railkar, A; Schoenfeld, RC; Slade, M; Steiner, S; Tan, YC; Villaseñor, AG; Wang, C; Wanner, J; Xie, W; Xu, D; Zhang, X; Zhou, M; Lucas, MC Pyrrolopyrazines as selective spleen tyrosine kinase inhibitors. J Med Chem 56: 1677-92 (2013)
- Lee, TR; Lawrence, DS SH2-directed ligands of the Lck tyrosine kinase. J Med Chem 43: 1173-9 (2000)
- Lee, K; Gao, Y; Yao, ZJ; Phan, J; Wu, L; Liang, J; Waugh, DS; Zhang, ZY; Burke, TR Tripeptide inhibitors of Yersinia protein-tyrosine phosphatase. Bioorg Med Chem Lett 13: 2577-81 (2003)
- Asante-Appiah, E; Patel, S; Desponts, C; Taylor, JM; Lau, C; Dufresne, C; Therien, M; Friesen, R; Becker, JW; Leblanc, Y; Kennedy, BP; Scapin, G Conformation-assisted inhibition of protein-tyrosine phosphatase-1B elicits inhibitor selectivity over T-cell protein-tyrosine phosphatase. J Biol Chem 281: 8010-5 (2006)
- Altman, MD; Cash, B; Ellis, JM; Maddess, ML; Northrup, AB; Otte, RD; Sun, B 2-pyrazine carboxamides as spleen tyrosine kinase inhibitors US Patent US9775839 (2017)
- Shen, J; Li, X; Zhang, Z; Luo, J; Long, H; Tu, Z; Zhou, X; Ding, K; Lu, X 3-aminopyrazolopyrazine derivatives as spleen tyrosine kinase inhibitors. Chem Biol Drug Des 88: 690-698 (2016)
- Bishop, AC; Blair, ER A gatekeeper residue for inhibitor sensitization of protein tyrosine phosphatases. Bioorg Med Chem Lett 16: 4002-6 (2006)
- BurkeJr., TR; Ford, H; Osherov, N; Levitzki, A; Stefanova, I; Horak, ID; Marquez, VE Arylamides of hydroxylated isoquinolines as protein-tyrosine kinase inhibitors Bioorg Med Chem Lett 2: 1771-1774 (1992)
- De Ford, C; Penchalaiah, K; Kreft, A; Humar, M; Heydenreuter, W; Kangani, M; Sieber, SA; Tietze, LF; Merfort, I Bifunctional Duocarmycin Analogues as Inhibitors of Protein Tyrosine Kinases. J Nat Prod 82: 16-26 (2019)
- Jake Slavish, P; Jiang, Q; Cui, X; Morris, SW; Webb, TR Design and synthesis of a novel tyrosine kinase inhibitor template. Bioorg Med Chem 17: 3308-16 (2009)
- Zhang, K; Ye, K; Tang, H; Qi, Z; Wang, T; Mao, J; Zhang, X; Jiang, S Development and Therapeutic Implications of Tyrosine Kinase 2 Inhibitors. J Med Chem 66: 4378-4416 (2023)
- Singh, R; Masuda, ES; Payan, DG Discovery and development of spleen tyrosine kinase (SYK) inhibitors. J Med Chem 55: 3614-43 (2012)
- PENDRI, A; LIU, H; POSY, SL; MU, Y; BRONSON, JJ; D''AGOSTINO, LA INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE US Patent US20240207238 (2024)
- Barf, T; de Zwart, E; Verkaik, S; Hoogenboom, N; Demont, D Imidazopyrazine inhibitors of Bruton's tyrosine kinase US Patent US11110088 (2021)
- Hopkins, BT; Ma, B; Prince, R; Marx, I; Lyssikatos, JP; Zheng, F; Peterson, M; Patience, DB Inhibiting agents for Bruton's tyrosine kinase US Patent US10961237 (2021)
- Hopkins, BT; Ma, B; Prince, R; Marx, I; Lyssikatos, JP Inhibiting agents for bruton's tyrosine kinase US Patent US10227341 (2019)
- Vang, T; Xie, Y; Liu, WH; Vidovic, D; Liu, Y; Wu, S; Smith, DH; Rinderspacher, A; Chung, C; Gong, G; Mustelin, T; Landry, DW; Rickert, RC; Schürer, SC; Deng, SX; Tautz, L Inhibition of lymphoid tyrosine phosphatase by benzofuran salicylic acids. J Med Chem 54: 562-71 (2011)
- Bobkova, EV; Liu, WH; Colayco, S; Rascon, J; Vasile, S; Gasior, C; Critton, DA; Chan, X; Dahl, R; Su, Y; Sergienko, E; Chung, TD; Mustelin, T; Page, R; Tautz, L Inhibition of the Hematopoietic Protein Tyrosine Phosphatase by Phenoxyacetic Acids. ACS Med Chem Lett 2: 113-118 (2011)
- Zhan, ZJ Multi-targeted tyrosine kinase inhibitors and their pharmaceutical uses US Patent US11912663 (2024)
- Horn, G Multi-tyrosine kinase inhibitors derivatives and methods of use US Patent US10464902 (2019)
- Vu, CB; Corpuz, EG; Pradeepan, SG; Violette, S; Bartlett, C; Sawyer, TK Nonpeptidic SH2 inhibitors of the tyrosine kinase ZAP-70. Bioorg Med Chem Lett 9: 3009-14 (1999)
- Rosse, G Novel Disubstituted Pyrimidines as Inhibitors of Bruton's Tyrosine Kinase. ACS Med Chem Lett 6: 23-4 (2015)
- Frechette, RF; Ackerman, C; Beers, S; Look, R; Moore, J Novel hydroxyphosphonate inhibitors of CD-45 tyrosine phosphatase Bioorg Med Chem Lett 7: 2169-2172 (1997)
- Bian, Z; Burke, JP; Jia, ZJ; Jiang, X; Katcher, MH; Mali, VR; Marin, VL; Noey, EL; Okano, A; Rivkin, AA; Scholz, SO; Woller, KR; Zhao, X; Adams, AM; Biannic, B; Mortezaei, S; Payette, JN; Zablocki, JA PYRIMIDINES FOR DEGRADING BRUTON'S TYROSINE KINASE US Patent US20240109877 (2024)
- LAWRENCE, NJ; LAWRENCE, HR; DUCKETT, D; REUTHER, G PYRIMIDINYL SULFONAMIDES AS INHIBITORS OF ACK1/TNK2 TYROSINE KINASE US Patent US20240010634 (2024)
- Leung, KW; Posner, BI; Just, G Periodinates: a new class of protein tyrosine phosphatase inhibitors. Bioorg Med Chem Lett 9: 353-6 (1999)
- Tautz, L; Senis, YA; Oury, C; Rahmouni, S Perspective: Tyrosine phosphatases as novel targets for antiplatelet therapy. Bioorg Med Chem 23: 2786-97 (2015)
- Burke, TR; Li, ZH; Bolen, JB; Marquez, VE Phosphonate-containing inhibitors of tyrosine-specific protein kinases. J Med Chem 34: 1577-81 (1991)
- He, W Polyfluorinated compounds acting as bruton tyrosine kinase inhibitors US Patent US10300066 (2019)
- Urbanek, RA; Suchard, SJ; Steelman, GB; Knappenberger, KS; Sygowski, LA; Veale, CA; Chapdelaine, MJ Potent reversible inhibitors of the protein tyrosine phosphatase CD45. J Med Chem 44: 1777-93 (2001)
- Xin, Z; Oost, TK; Abad-Zapatero, C; Hajduk, PJ; Pei, Z; Szczepankiewicz, BG; Hutchins, CW; Ballaron, SJ; Stashko, MA; Lubben, T; Trevillyan, JM; Jirousek, MR; Liu, G Potent, selective inhibitors of protein tyrosine phosphatase 1B. Bioorg Med Chem Lett 13: 1887-90 (2003)
- Zhou, J; Wu, Z; Oyawaluja, BO; Coker, HAB; Odukoya, OA; Yao, G; Che, CT Protein Tyrosine Phosphatase 1B Inhibitory Iridoids from J Nat Prod 82: 2916-2924 (2019)
- Furet, P; Graus Porta, D; Guagnano, V Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors US Patent US8815901 (2014)
- Furet, P; Graus Porta, D; Guagnano, V Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors US Patent US8536175 (2013)
- Haidle, AM; Burch, J; Guay, D; Gauthier, JY; Robichaud, J; Fournier, JF; Ellis, JM; Christopher, M; Kattar, SD; Smith, GF; Northrup, AB Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitors US Patent US9353066 (2016)
- Bullington, JL; Cameron, JC; Davis, JE; Dodd, JH; Harris, CA; Henry, JR; Pellegrino-Gensey, JL; Rupert, KC; Siekierka, JJ The development of novel and selective p56lck tyrosine kinase inhibitors. Bioorg Med Chem Lett 8: 2489-94 (1999)
- Miller, TA; Petrocchi, A; Romeo, ET; Vitharana, D; Kattar, SD; Northrup, AB; Altman, MD; Anthony, NJ Thiazole-substituted aminoheteroaryls as Spleen Tyrosine Kinase inhibitors US Patent US9670196 (2017)
- Altman, MD; Andresen, BM; Arrington, KL; Childers, KK; Di Francesco, ME; Ellis, JM; Haidle, AM; Liu, Y; Northrup, AB; O Boyle, B; Otte, RD; Reutershan, MH; Vitharana, D; Woo, HC Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors US Patent US9598405 (2017)
- Arrington, KL; DuBois, B; Debenham, JS; Liu, P; Northrup, AB; Szewczyk, JW; Wang, L; Wang, M Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors US Patent US9499534 (2016)
- Ma, Y; Sun, SX; Cheng, XC; Wang, SQ; Dong, WL; Wang, RL; Xu, WR Design and synthesis of imidazolidine-2,4-dione derivatives as selective inhibitors by targeting protein tyrosine phosphatase-1B over T-cell protein tyrosine phosphatase. Chem Biol Drug Des 82: 595-602 (2013)
- Maccari, R; Paoli, P; Ottanà, R; Jacomelli, M; Ciurleo, R; Manao, G; Steindl, T; Langer, T; Vigorita, MG; Camici, G 5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases. Bioorg Med Chem 15: 5137-49 (2007)
- Wang, Y; Ren, X; Jin, J; Li, H; Ai, Y Amino pyrimidine compound for inhibiting protein tyrosine kinase activity US Patent US11111233 (2021)
- Romeo, ET; Machacek, MR; Trotter, BW; Miller, TA; Andresen, BM; Anthony, NJ; Taoka, BM; Liu, Y Amino-pyridine-containing spleen tyrosine kinase (SYK) inhibitors US Patent US8796310 (2014)
- Machacek, MR Amino-pyrimidine-containing spleen tyrosine kinase (Syk) inhibitors US Patent US9624210 (2017)
- Moretto, AF; Kirincich, SJ; Xu, WX; Smith, MJ; Wan, ZK; Wilson, DP; Follows, BC; Binnun, E; Joseph-McCarthy, D; Foreman, K; Erbe, DV; Zhang, YL; Tam, SK; Tam, SY; Lee, J Bicyclic and tricyclic thiophenes as protein tyrosine phosphatase 1B inhibitors. Bioorg Med Chem 14: 2162-77 (2006)
- Shi, D; Li, J; Jiang, B; Guo, S; Su, H; Wang, T Bromophenols as inhibitors of protein tyrosine phosphatase 1B with antidiabetic properties. Bioorg Med Chem Lett 22: 2827-32 (2012)
- Kargbo, RB Bruton's Tyrosine Kinase Inhibitors for the Treatment of Autoimmune Diseases and Cancers. ACS Med Chem Lett 8: 911-913 (2017)
- Buldenko, VM; Trush, VV; Kobzar, OL; Drapailo, AB; Kalchenko, VI; Vovk, AI Calixarene-based phosphinic acids as inhibitors of protein tyrosine phosphatases. Bioorg Med Chem Lett 29: 797-801 (2019)
- Sasaki, T; Li, W; Higai, K; Koike, K Canthinone alkaloids are novel protein tyrosine phosphatase 1B inhibitors. Bioorg Med Chem Lett 25: 1979-81 (2015)
- Wang, X; Liu, J; Zhang, W; Stashko, MA; Nichols, J; Miley, MJ; Norris-Drouin, J; Chen, Z; Machius, M; DeRyckere, D; Wood, E; Graham, DK; Earp, HS; Kireev, D; Frye, SV Design and Synthesis of Novel Macrocyclic Mer Tyrosine Kinase Inhibitors. ACS Med Chem Lett 7: 1044-1049 (2016)
- Chen, JJ; Thakur, KD; Clark, MP; Laughlin, SK; George, KM; Bookland, RG; Davis, JR; Cabrera, EJ; Easwaran, V; De, B; George Zhang, Y Development of pyrimidine-based inhibitors of Janus tyrosine kinase 3. Bioorg Med Chem Lett 16: 5633-8 (2006)
- Benjahad, A; Martin, J; Schalon, C; Pez, D; Chevenier, E; Sandrinelli, F; Picoul, W; Moussy, A Diazaspiroalkaneone-substituted oxazole derivatives as spleen tyrosine kinase inhibitors US Patent US10053455 (2018)
- Archibald, SC; Head, JC; Gozzard, N; Howat, DW; Parton, TA; Porter, JR; Robinson, MK; Shock, A; Warrellow, GJ; Abraham, WM Discovery and evaluation of potent, tyrosine-based alpha4beta1 integrin antagonists. Bioorg Med Chem Lett 10: 997-9 (2000)
- Choi, Y; Syeda, F; Walker, JR; Finerty, PJ; Cuerrier, D; Wojciechowski, A; Liu, Q; Dhe-Paganon, S; Gray, NS Discovery and structural analysis of Eph receptor tyrosine kinase inhibitors. Bioorg Med Chem Lett 19: 4467-70 (2009)
- Ge, Y; Jin, Y; Wang, C; Zhang, J; Tang, Z; Peng, J; Liu, K; Li, Y; Zhou, Y; Ma, X Discovery of Novel Bruton's Tyrosine Kinase (BTK) Inhibitors Bearing a ACS Med Chem Lett 7: 1050-1055 (2016)
- Xie, Y; Liu, Y; Gong, G; Rinderspacher, A; Deng, SX; Smith, DH; Toebben, U; Tzilianos, E; Branden, L; Vidovic, D; Chung, C; Schürer, S; Tautz, L; Landry, DW Discovery of a novel submicromolar inhibitor of the lymphoid specific tyrosine phosphatase. Bioorg Med Chem Lett 18: 2840-4 (2008)
- Kim, HG; Tan, L; Weisberg, EL; Liu, F; Canning, P; Choi, HG; Ezell, SA; Wu, H; Zhao, Z; Wang, J; Mandinova, A; Griffin, JD; Bullock, AN; Liu, Q; Lee, SW; Gray, NS Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor. ACS Chem Biol 8: 2145-50 (2013)
- Qiu, H; Ali, Z; Bender, A; Caldwell, R; Chen, YY; Fang, Z; Gardberg, A; Glaser, N; Goettsche, A; Goutopoulos, A; Grenningloh, R; Hanschke, B; Head, J; Johnson, T; Jones, C; Jones, R; Kulkarni, S; Maurer, C; Morandi, F; Neagu, C; Poetzsch, S; Potnick, J; Schmidt, R; Roe, K; Viacava Follis, A; Wing, C; Zhu, X; Sherer, B Discovery of potent and selective reversible Bruton's tyrosine kinase inhibitors. Bioorg Med Chem 40: (2021)
- Lu, J; Huang, Y; Huang, J; He, R; Huang, M; Lu, X; Xu, Y; Zhou, F; Zhang, Z; Ding, K Discovery of the First Examples of Threonine Tyrosine Kinase PROTAC Degraders. J Med Chem 65: 2313-2328 (2022)
- Li, W; Li, S; Higai, K; Sasaki, T; Asada, Y; Ohshima, S; Koike, K Evaluation of licorice flavonoids as protein tyrosine phosphatase 1B inhibitors. Bioorg Med Chem Lett 23: 5836-9 (2013)
- Shrestha, S; Shim, YS; Kim, KC; Lee, KH; Cho, H Evans Blue and other dyes as protein tyrosine phosphatase inhibitors. Bioorg Med Chem Lett 14: 1923-6 (2004)
- Marseigne, I; Roy, P; Dor, A; Durieux, C; Pélaprat, D; Reibaud, M; Blanchard, JC; Roques, BP Full agonists of CCK8 containing a nonhydrolyzable sulfated tyrosine residue. J Med Chem 32: 445-9 (1989)
- Dolle, RE; Michaut, M; Martinez-Teipel, B; Belanger, S; Graczyk, TM; DeHaven, RN Further studies of tyrosine surrogates in opioid receptor peptide ligands. Bioorg Med Chem Lett 17: 2656-60 (2007)
- Vovk, AI; Kononets, LA; Tanchuk, VY; Cherenok, SO; Drapailo, AB; Kalchenko, VI; Kukhar, VP Inhibition of Yersinia protein tyrosine phosphatase by phosphonate derivatives of calixarenes. Bioorg Med Chem Lett 20: 483-7 (2010)
- Gourzoulidou, E; Carpintero, M; Baumhof, P; Giannis, A; Waldmann, H Inhibition of angiogenesis-relevant receptor tyrosine kinases by sulindac analogues. Chembiochem 6: 527-31 (2005)
- Arora, N; Bacani, GM; Barbay, JK; Bembenek, SD; Cai, M; Chen, W; Deckhut, CP; Edwards, JP; Ghosh, B; Hao, B; Kreutter, KD; Li, G; Tichenor, MS; Venable, JD; Wei, J; Wiener, JJ; Wu, Y; Zhu, Y; Zhang, F; Zhang, Z; Xiao, K Inhibitors of Bruton's tyrosine kinase and method of their use US Patent US10800792 (2020)
- Arora, N; Bacani, GM; Barbay, JK; Bembenek, SD; Cai, M; Chen, W; Deckhut, CP; Edwards, JP; Ghosh, B; Hao, B; Kreutter, KD; Li, G; Tichenor, MS; Venable, JD; Wei, J; Wiener, JJ; Wu, Y; Zhu, Y; Zhang, F; Zhang, Z; Xiao, K Inhibitors of Bruton's tyrosine kinase and methods of their use US Patent US10822348 (2020)
- Suárez, RM; Chevot, F; Cavagnino, A; Saettel, N; Radvanyi, F; Piguel, S; Bernard-Pierrot, I; Stoven, V; Legraverend, M Inhibitors of the TAM subfamily of tyrosine kinases: synthesis and biological evaluation. Eur J Med Chem 61: 2-25 (2013)
- Augustyn, E; Finke, K; Zur, AA; Hansen, L; Heeren, N; Chien, HC; Lin, L; Giacomini, KM; Colas, C; Schlessinger, A; Thomas, AA LAT-1 activity of meta-substituted phenylalanine and tyrosine analogs. Bioorg Med Chem Lett 26: 2616-2621 (2016)
- Zhan, ZJ Multi-targeted tyrosine kinase inhibitors effective in antitumor uses US Patent US12071408 (2024)
- Jin, J; Wang, Y; Shi, D; Wang, F; Fu, W; Davis, RS; Jin, Q; Foley, JJ; Sarau, HM; Morrow, DM; Moore, ML; Rivero, RA; Palovich, M; Salmon, M; Belmonte, KE; Busch-Petersen, J Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas. Bioorg Med Chem Lett 18: 5481-6 (2008)
- Fink, BE; Vite, GD; Mastalerz, H; Kadow, JF; Kim, SH; Leavitt, KJ; Du, K; Crews, D; Mitt, T; Wong, TW; Hunt, JT; Vyas, DM; Tokarski, JS New dual inhibitors of EGFR and HER2 protein tyrosine kinases. Bioorg Med Chem Lett 15: 4774-9 (2005)
- Kammasud, N; Boonyarat, C; Tsunoda, S; Sakurai, H; Saiki, I; Grierson, DS; Vajragupta, O Novel inhibitor for fibroblast growth factor receptor tyrosine kinase. Bioorg Med Chem Lett 17: 4812-8 (2007)
- Bhattacharya, S; Labutti, JN; Seiner, DR; Gates, KS Oxidative inactivation of protein tyrosine phosphatase 1B by organic hydroperoxides. Bioorg Med Chem Lett 18: 5856-9 (2008)
- Brazeau, JF; Rosse, G Phenyl carboxamide analogues as spleen tyrosine kinase (syk) inhibitors. ACS Med Chem Lett 5: 278-9 (2014)
- Lai, JY; Cox, PJ; Patel, R; Sadiq, S; Aldous, DJ; Thurairatnam, S; Smith, K; Wheeler, D; Jagpal, S; Parveen, S; Fenton, G; Harrison, TK; McCarthy, C; Bamborough, P Potent small molecule inhibitors of spleen tyrosine kinase (Syk). Bioorg Med Chem Lett 13: 3111-4 (2003)
- Hooft van Huijsduijnen, R; Sauer, WH; Bombrun, A; Swinnen, D Prospects for inhibitors of protein tyrosine phosphatase 1B as antidiabetic drugs. J Med Chem 47: 4142-6 (2004)
- Ettmayer, P; Mantoulidis, A Pyrimido [5,4-D] pyrimidine derivatives for the inhibition of tyrosine kinases US Patent US8569316 (2013)
- Peng, S; Liao, C; Chen, H; Ho, C; Huang, H; Chiou, S Quinoxaline compounds as type III receptor tyrosine kinase inhibitors US Patent US10689362 (2020)
- Lucas, MC; Goldstein, DM; Hermann, JC; Kuglstatter, A; Liu, W; Luk, KC; Padilla, F; Slade, M; Villaseñor, AG; Wanner, J; Xie, W; Zhang, X; Liao, C Rational design of highly selective spleen tyrosine kinase inhibitors. J Med Chem 55: 10414-23 (2012)
- Kong, J; Long, YQ Recent advances in the discovery of protein tyrosine phosphatase SHP2 inhibitors. RSC Med Chem 13: 246-257 (2022)
- Wang, Z; Qu, S; Yuan, J; Tian, W; Xu, J; Tao, R; Sun, S; Lu, T; Tang, W; Zhu, Y Review and prospects of targeted therapies for Spleen tyrosine kinase (SYK). Bioorg Med Chem 96: (2023)
- Song, Y; Wang, S; Zhao, M; Yang, X; Yu, B Strategies Targeting Protein Tyrosine Phosphatase SHP2 for Cancer Therapy. J Med Chem 65: 3066-3079 (2022)
- De Filippis, B; Linciano, P; Ammazzalorso, A; Di Giovanni, C; Fantacuzzi, M; Giampietro, L; Laghezza, A; Maccallini, C; Tortorella, P; Lavecchia, A; Loiodice, F; Amoroso, R Structural development studies of PPARs ligands based on tyrosine scaffold. Eur J Med Chem 89: 817-25 (2014)
- Black, E; Breed, J; Breeze, AL; Embrey, K; Garcia, R; Gero, TW; Godfrey, L; Kenny, PW; Morley, AD; Minshull, CA; Pannifer, AD; Read, J; Rees, A; Russell, DJ; Toader, D; Tucker, J Structure-based design of protein tyrosine phosphatase-1B inhibitors. Bioorg Med Chem Lett 15: 2503-7 (2005)
- Whitlock, GA; Glossop, PA Substituted pyrimidine-5-carboxamides as spleen tyrosine kinase inhibitors US Patent US9533989 (2017)
- Zhang, D Substituted quinolines as bruton's tyrosine kinases inhibitors US Patent US9353062 (2016)
- Ibrahimi, OA; Wu, L; Zhao, K; Zhang, ZY Synthesis and characterization of a novel class of protein tyrosine phosphatase inhibitors. Bioorg Med Chem Lett 10: 457-60 (2000)
- Cushman, M; Nagarathnam, D; Burg, DL; Geahlen, RL Synthesis and protein-tyrosine kinase inhibitory activities of flavonoid analogues. J Med Chem 34: 798-806 (1991)
- Rachid, Z; Katsoulas, A; Brahimi, F; Jean-Claude, BJ Synthesis of pyrimidinopyridine-triazene conjugates targeted to abl tyrosine kinase. Bioorg Med Chem Lett 13: 3297-300 (2003)
- Lee, K; Boovanahalli, SK; Nam, KY; Kang, SU; Lee, M; Phan, J; Wu, L; Waugh, DS; Zhang, ZY; No, KT; Lee, JJ; Burke, TR Synthesis of tripeptides as potent Yersinia protein tyrosine phosphatase inhibitors. Bioorg Med Chem Lett 15: 4037-42 (2005)
- Apsel, B; Blair, JA; Gonzalez, B; Nazif, TM; Feldman, ME; Aizenstein, B; Hoffman, R; Williams, RL; Shokat, KM; Knight, ZA Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases. Nat Chem Biol 4: 691-9 (2008)
- Huby, NJ; Lopez-Tapia, FJ; So, S Thiazole derivatives as inhibitors of Bruton's tyrosine kinase US Patent US9359345 (2016)
- Hegde, R Use of small molecule inhibitors targeting EYA tyrosine phosphatase US Patent US9962362 (2018)
- Chen, YT; Onaran, MB; Doss, CJ; Seto, CT alpha-Ketocarboxylic acid-based inhibitors of protein tyrosine phosphatases. Bioorg Med Chem Lett 11: 1935-8 (2001)
- Rangel-Grimaldo, M; Macías-Rubalcava, ML; González-Andrade, M; Raja, H; Figueroa, M; Mata, R ?-Glucosidase and Protein Tyrosine Phosphatase 1B Inhibitors from J Nat Prod 83: 675-683 (2020)
- Sun, L; Tran, N; Tang, F; App, H; Hirth, P; McMahon, G; Tang, C Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases. J Med Chem 41: 2588-603 (1998)
- Klutchko, SR; Zhou, H; Winters, RT; Tran, TP; Bridges, AJ; Althaus, IW; Amato, DM; Elliott, WL; Ellis, PA; Meade, MA; Roberts, BJ; Fry, DW; Gonzales, AJ; Harvey, PJ; Nelson, JM; Sherwood, V; Han, HK; Pace, G; Smaill, JB; Denny, WA; Showalter, HD Tyrosine kinase inhibitors. 19. 6-Alkynamides of 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as irreversible inhibitors of the erbB family of tyrosine kinase receptors. J Med Chem 49: 1475-85 (2006)
- Rewcastle, GW; Palmer, BD; Bridges, AJ; Showalter, HD; Sun, L; Nelson, J; McMichael, A; Kraker, AJ; Fry, DW; Denny, WA Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor. J Med Chem 39: 918-28 (1996)
- Wang, J; Fan, C; Zhang, L; Guo, Z; Li, Y; Yang, S; Yan, S; Zhu, J; Yang, Q; Zhang, M 4-(substituted anilino)-quinazoline derivatives useful as tyrosine kinase inhibitors US Patent US8916574 (2014)
- Burke, TR; Lim, B; Marquez, VE; Li, ZH; Bolen, JB; Stefanova, I; Horak, ID Bicyclic compounds as ring-constrained inhibitors of protein-tyrosine kinase p56lck. J Med Chem 36: 425-32 (1993)
- Stuible, M; Zhao, L; Aubry, I; Schmidt-Arras, D; Böhmer, FD; Li, CJ; Tremblay, ML Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives. Chembiochem 8: 179-86 (2007)
- Zhang, W; McIver, AL; Stashko, MA; DeRyckere, D; Branchford, BR; Hunter, D; Kireev, D; Miley, MJ; Norris-Drouin, J; Stewart, WM; Lee, M; Sather, S; Zhou, Y; Di Paola, JA; Machius, M; Janzen, WP; Earp, HS; Graham, DK; Frye, SV; Wang, X Discovery of Mer specific tyrosine kinase inhibitors for the treatment and prevention of thrombosis. J Med Chem 56: 9693-700 (2014)
- Leit, S; Greenwood, J; Carriero, S; Mondal, S; Abel, R; Ashwell, M; Blanchette, H; Boyles, NA; Cartwright, M; Collis, A; Feng, S; Ghanakota, P; Harriman, GC; Hosagrahara, V; Kaila, N; Kapeller, R; Rafi, SB; Romero, DL; Tarantino, PM; Timaniya, J; Toms, AV; Wester, RT; Westlin, W; Srivastava, B; Miao, W; Tummino, P; McElwee, JJ; Edmondson, SD; Masse, CE Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279. J Med Chem 66: 10473-10496 (2023)
- Vu, CB; Corpuz, EG; Merry, TJ; Pradeepan, SG; Bartlett, C; Bohacek, RS; Botfield, MC; Eyermann, CJ; Lynch, BA; MacNeil, IA; Ram, MK; van Schravendijk, MR; Violette, S; Sawyer, TK Discovery of potent and selective SH2 inhibitors of the tyrosine kinase ZAP-70. J Med Chem 42: 4088-98 (1999)
- Fu, T; Zuo, Y; Zhong, Z; Chen, X; Pan, Z Discovery of selective irreversible inhibitors of B-Lymphoid tyrosine kinase (BLK). Eur J Med Chem 229: (2022)
- Sabat, M; Dougan, DR; Knight, B; Lawson, JD; Scorah, N; Smith, CR; Taylor, ER; Vu, P; Wyrick, C; Wang, H; Balakrishna, D; Hixon, M; Madakamutil, L; McConn, D Discovery of the Bruton's Tyrosine Kinase Inhibitor Clinical Candidate TAK-020 ( J Med Chem 64: 12893-12902 (2021)
- Chen, YT; Seto, CT Divalent and trivalent alpha-ketocarboxylic acids as inhibitors of protein tyrosine phosphatases. J Med Chem 45: 3946-52 (2002)
- Shan, Y; Wang, C; Zhang, L; Wang, J; Wang, M; Dong, Y Expanding the structural diversity of diarylureas as multi-target tyrosine kinase inhibitors. Bioorg Med Chem 24: 750-8 (2016)
- Shim, YS; Kim, KC; Chi, DY; Lee, KH; Cho, H Formylchromone derivatives as a novel class of protein tyrosine phosphatase 1B inhibitors. Bioorg Med Chem Lett 13: 2561-3 (2003)
- Smith, CR; Dougan, DR; Komandla, M; Kanouni, T; Knight, B; Lawson, JD; Sabat, M; Taylor, ER; Vu, P; Wyrick, C Fragment-Based Discovery of a Small Molecule Inhibitor of Bruton's Tyrosine Kinase. J Med Chem 58: 5437-44 (2015)
- Ozvegy-Laczka, C; Hegedus, T; Várady, G; Ujhelly, O; Schuetz, JD; Váradi, A; Kéri, G; Orfi, L; Német, K; Sarkadi, B High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter. Mol Pharmacol 65: 1485-95 (2004)
- Smyth, MS; Stefanova, I; Horak, ID; Burke, TR Hydroxylated 2-(5'-salicyl)naphthalenes as protein-tyrosine kinase inhibitors. J Med Chem 36: 3015-20 (1993)
- Raeppel, SL; Gaudette, F; Nguyen, H; Beaulieu, N; Wang, J; Maroun, C; Besterman, JM; Vaisburg, A Identification of a Novel Series of Potent TrkA Receptor Tyrosine Kinase Inhibitors International Journal of Medicinal Chemistry 2012: 1-6 (2012)
- Kawatkar, SP; Barlaam, B; Kemmitt, P; Simpson, I; Watson, D; Wang, P; Lamont, S; Su, Q; Boiko, S; Ikeda, T; Patel, J; Pike, A; Pollard, H; Read, J; Sarkar, U; Wang, H; Wen, Q; Yan, Z; Dowling, JE; Dry, H; Edmondson, SD Identification of a novel series of azabenzimidazole-derived inhibitors of spleen tyrosine kinase. Bioorg Med Chem Lett 30: (2020)
- Raeppel, S; Gaudette, F; Mannion, M; Claridge, S; Saavedra, O; Isakovic, L; Déziel, R; Beaulieu, N; Beaulieu, C; Dupont, I; Nguyen, H; Wang, J; Macleod, AR; Maroun, C; Besterman, JM; Vaisburg, A Identification of a novel series of potent RON receptor tyrosine kinase inhibitors. Bioorg Med Chem Lett 20: 2745-9 (2010)
- LaRochelle, JR; Fodor, M; Ellegast, JM; Liu, X; Vemulapalli, V; Mohseni, M; Stams, T; Buhrlage, SJ; Stegmaier, K; LaMarche, MJ; Acker, MG; Blacklow, SC Identification of an allosteric benzothiazolopyrimidone inhibitor of the oncogenic protein tyrosine phosphatase SHP2. Bioorg Med Chem 25: 6479-6485 (2017)
- Liu, W; Yu, B; Xu, G; Xu, WR; Loh, ML; Tang, LD; Qu, CK Identification of cryptotanshinone as an inhibitor of oncogenic protein tyrosine phosphatase SHP2 (PTPN11). J Med Chem 56: 7212-21 (2013)
- Adisakwattana, S; Pongsuwan, J; Wungcharoen, C; Yibchok-anun, S In vitro effects of cinnamic acid derivatives on protein tyrosine phosphatase 1B. J Enzyme Inhib Med Chem 28: 1067-72 (2013)
- Honigberg, L; Verner, E; Buggy, J; Loury, D; Chen, W Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors US Patent US9278100 (2016)
- Bottini, N; Zou, J; Ganji, SR; Stanford, S; Pinkerton, A; Chung, TD; Hedrick, M; Ardecky, R Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof US Patent US10626094 (2020)
- Isolation of a novel tyrosine kinase inhibitor, lavendustin A, from Streptomyces griseolavendus.
- Ji, Z; Ahmed, AA; Albert, DH; Bouska, JJ; Bousquet, PF; Cunha, GA; Glaser, KB; Guo, J; Li, J; Marcotte, PA; Moskey, MD; Pease, LJ; Stewart, KD; Yates, M; Davidsen, SK; Michaelides, MR Isothiazolopyrimidines and isoxazolopyrimidines as novel multi-targeted inhibitors of receptor tyrosine kinases. Bioorg Med Chem Lett 16: 4326-30 (2006)
- Zhao, H; Liu, G; Xin, Z; Serby, MD; Pei, Z; Szczepankiewicz, BG; Hajduk, PJ; Abad-Zapatero, C; Hutchins, CW; Lubben, TH; Ballaron, SJ; Haasch, DL; Kaszubska, W; Rondinone, CM; Trevillyan, JM; Jirousek, MR Isoxazole carboxylic acids as protein tyrosine phosphatase 1B (PTP1B) inhibitors. Bioorg Med Chem Lett 14: 5543-6 (2004)
- LYSSIKATOS, JP; REN, L; KINTZ, S NAPHTHYRIDONE COMPOUNDS FOR INHIBITION OF RAF KINASES AND/OR BCR-ABL TYROSINE KINASES US Patent US20240287062 (2024)
- Wang, Q; Huang, Z; Ramachandran, C; Dinaut, AN; Taylor, SD Naphthalenebis[alpha,alpha-difluoromethylenephosphonates] as potent inhibitors of protein tyrosine phosphatases. Bioorg Med Chem Lett 8: 345-50 (1999)
- Malamas, MS; Sredy, J; Gunawan, I; Mihan, B; Sawicki, DR; Seestaller, L; Sullivan, D; Flam, BR New azolidinediones as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties. J Med Chem 43: 995-1010 (2000)
- Smyth, MS; Stefanova, I; Hartmann, F; Horak, ID; Osherov, N; Levitzki, A; Burke, TR Non-amine based analogues of lavendustin A as protein-tyrosine kinase inhibitors. J Med Chem 36: 3010-4 (1993)
- Young, WB; Barbosa, J; Blomgren, P; Bremer, MC; Crawford, JJ; Dambach, D; Gallion, S; Hymowitz, SG; Kropf, JE; Lee, SH; Liu, L; Lubach, JW; Macaluso, J; Maciejewski, P; Maurer, B; Mitchell, SA; Ortwine, DF; Di Paolo, J; Reif, K; Scheerens, H; Schmitt, A; Sowell, CG; Wang, X; Wong, H; Xiong, JM; Xu, J; Zhao, Z; Currie, KS Potent and selective Bruton's tyrosine kinase inhibitors: discovery of GDC-0834. Bioorg Med Chem Lett 25: 1333-7 (2015)
- Cui, L; Na, M; Oh, H; Bae, EY; Jeong, DG; Ryu, SE; Kim, S; Kim, BY; Oh, WK; Ahn, JS Protein tyrosine phosphatase 1B inhibitors from Morus root bark. Bioorg Med Chem Lett 16: 1426-9 (2006)
- Hoang, DM; Ngoc, TM; Dat, NT; Ha, do T; Kim, YH; Luong, HV; Ahn, JS; Bae, K Protein tyrosine phosphatase 1B inhibitors isolated from Morus bombycis. Bioorg Med Chem Lett 19: 6759-61 (2009)
- Chang, CJ; Geahlen, RL Protein-Tyrosine Kinase Inhibition: Mechanism-Based Discovery of Antitumor Agents J Nat Prod 55: 1529-1560 (1992)
- Wilke, KE; Fihn, CA; Carlson, EE Screening serine/threonine and tyrosine kinase inhibitors for histidine kinase inhibition. Bioorg Med Chem 26: 5322-5326 (2018)
- Zhou, X; Liu, X; Hu, M Selective Bruton's tyrosine kinase inhibitor and use thereof US Patent US10711006 (2020)
- Yu, ZH; Chen, L; Wu, L; Liu, S; Wang, L; Zhang, ZY Small molecule inhibitors of SHP2 tyrosine phosphatase discovered by virtual screening. Bioorg Med Chem Lett 21: 4238-42 (2011)
- Qiao, L; Choi, S; Case, A; Gainer, TG; Seyb, K; Glicksman, MA; Lo, DC; Stein, RL; Cuny, GD Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors. Bioorg Med Chem Lett 19: 6122-6 (2009)
- Jung, HA; Paudel, P; Seong, SH; Min, BS; Choi, JS Structure-related protein tyrosine phosphatase 1B inhibition by naringenin derivatives. Bioorg Med Chem Lett 27: 2274-2280 (2017)
- Hamaguchi, T; Takahashi, A; Kagamizono, T; Manaka, A; Sato, M; Osada, H Synthesis and characterization of a potent and selective protein tyrosine phosphatase inhibitor, 2. Bioorg Med Chem Lett 10: 2657-60 (2000)
- Lü, S; Luo, Q; Hao, X; Li, X; Ji, L; Zheng, W; Wang, F Synthesis and docking study of 2-phenylaminopyrimidine Abl tyrosine kinase inhibitors. Bioorg Med Chem Lett 21: 6964-8 (2011)
- East, JE; Kennedy, AJ; Tomsig, JL; De Leon, AR; Lynch, KR; Macdonald, TL Synthesis and structure-activity relationships of tyrosine-based inhibitors of autotaxin (ATX). Bioorg Med Chem Lett 20: 7132-6 (2010)
- Maurya, R; Gupta, P; Ahmad, G; Yadav, DK; Chand, K; Singh, AB; Tamrakar, AK; Srivastava, AK Synthesis of 3,5-disubstituted isoxazolines as protein tyrosine phosphatase 1B inhibitors Medicinal Chemistry Research 17: 123-136 (2008)
- Ahmad, G; Mishra, PK; Gupta, P; Yadav, PP; Tiwari, P; Tamrakar, AK; Srivastava, AK; Maurya, R Synthesis of novel benzofuran isoxazolines as protein tyrosine phosphatase 1B inhibitors. Bioorg Med Chem Lett 16: 2139-43 (2006)
- Puder, C; Wagner, K; Vettermann, R; Hauptmann, R; Potterat, O Terphenylquinone inhibitors of the src protein tyrosine kinase from Stilbella sp. J Nat Prod 68: 323-6 (2005)
- Hantschel, O; Rix, U; Schmidt, U; Bürckstümmer, T; Kneidinger, M; Schütze, G; Colinge, J; Bennett, KL; Ellmeier, W; Valent, P; Superti-Furga, G The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib. Proc Natl Acad Sci U S A 104: 13283-8 (2007)
- Kim, MH; Tsuhako, AL; Co, EW; Aftab, DT; Bentzien, F; Chen, J; Cheng, W; Engst, S; Goon, L; Klein, RR; Le, DT; Mac, M; Parks, JJ; Qian, F; Rodriquez, M; Stout, TJ; Till, JH; Won, KA; Wu, X; Yakes, FM; Yu, P; Zhang, W; Zhao, Y; Lamb, P; Nuss, JM; Xu, W The design, synthesis, and biological evaluation of potent receptor tyrosine kinase inhibitors. Bioorg Med Chem Lett 22: 4979-85 (2012)
- Dai, Y; Guo, Y; Frey, RR; Ji, Z; Curtin, ML; Ahmed, AA; Albert, DH; Arnold, L; Arries, SS; Barlozzari, T; Bauch, JL; Bouska, JJ; Bousquet, PF; Cunha, GA; Glaser, KB; Guo, J; Li, J; Marcotte, PA; Marsh, KC; Moskey, MD; Pease, LJ; Stewart, KD; Stoll, VS; Tapang, P; Wishart, N; Davidsen, SK; Michaelides, MR Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors. J Med Chem 48: 6066-83 (2005)
- Gazit, A; Yaish, P; Gilon, C; Levitzki, A Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. J Med Chem 32: 2344-52 (1989)
- Cai, Y; Lu, D; Chen, Z; Ding, Y; Chung, NN; Li, T; Schiller, PW [Dmt(1)]DALDA analogues modified with tyrosine analogues at position 1. Bioorg Med Chem Lett 26: 3629-31 (2016)
- Palmer, BD; Rewcastle, GW; Thompson, AM; Boyd, M; Showalter, HD; Sercel, AD; Fry, DW; Kraker, AJ; Denny, WA Tyrosine kinase inhibitors. 4. Structure-activity relationships among N- and 3-substituted 2,2'-dithiobis(1H-indoles) for in vitro inhibition of receptor and nonreceptor protein tyrosine kinases. J Med Chem 38: 58-67 (1995)
- Kraj?ovi?ová, S; Jorda, R; Vanda, D; Soural, M; Kry?tof, V 1,4,6-Trisubstituted imidazo[4,5-c]pyridines as inhibitors of Bruton's tyrosine kinase. Eur J Med Chem 211: (2021)
- Lim, CJ; Oh, KS; Ha, JD; Lee, JH; Seo, HW; Chae, CH; Kim, DG; Lee, MJ; Lee, BH 4-Substituted quinazoline derivatives as novel EphA2 receptor tyrosine kinase inhibitors. Bioorg Med Chem Lett 24: 4080-3 (2014)
- Frey, RR; Curtin, ML; Albert, DH; Glaser, KB; Pease, LJ; Soni, NB; Bouska, JJ; Reuter, D; Stewart, KD; Marcotte, P; Bukofzer, G; Li, J; Davidsen, SK; Michaelides, MR 7-Aminopyrazolo[1,5-a]pyrimidines as potent multitargeted receptor tyrosine kinase inhibitors. J Med Chem 51: 3777-87 (2008)
- Wessels, M; König, GM; Wright, AD A new tyrosine kinase inhibitor from the marine brown alga Stypopodium zonale. J Nat Prod 62: 927-30 (1999)
- Zhu, L; Hu, Y; Wu, W; Dai, L; Duan, X; Yang, Y; Sun, Y; Han, Y; Peng, Y; Kong, F; Luo, H; Yang, L; Xu, H; Guo, M; Zhong, Z; Wang, S Amino pyrazolopyrimidine compound used as neurotrophic factor tyrosine kinase receptor inhibitor US Patent US10829492 (2020)
- Cheng, W; Wang, M; Tian, X; Zhang, X An overview of the binding models of FGFR tyrosine kinases in complex with small molecule inhibitors. Eur J Med Chem 126: 476-490 (2017)
- Miski, M; Xing, Shen; Cooper, R; Gillum, AM; Fisher, DK; Miller, RW; Higgins, TJ Aporphine alkaloids, CD45 protein tyrosine phosphatase inhibitors, from Rollinia ulei Bioorg Med Chem Lett 5: 1519-1522 (1995)
- Sparks, RB; Polam, P; Zhu, W; Crawley, ML; Takvorian, A; McLaughlin, E; Wei, M; Ala, PJ; Gonneville, L; Taylor, N; Li, Y; Wynn, R; Burn, TC; Liu, PC; Combs, AP Benzothiazole benzimidazole (S)-isothiazolidinone derivatives as protein tyrosine phosphatase-1B inhibitors. Bioorg Med Chem Lett 17: 736-40 (2007)
- He, Y; Zeng, LF; Yu, ZH; He, R; Liu, S; Zhang, ZY Bicyclic benzofuran and indole-based salicylic acids as protein tyrosine phosphatase inhibitors. Bioorg Med Chem 20: 1940-6 (2012)
- Trush, VV; Cherenok, SO; Tanchuk, VY; Kukhar, VP; Kalchenko, VI; Vovk, AI Calix[4]arene methylenebisphosphonic acids as inhibitors of protein tyrosine phosphatase 1B. Bioorg Med Chem Lett 23: 5619-23 (2013)
- Lipchock, JM; Hendrickson, HP; Douglas, BB; Bird, KE; Ginther, PS; Rivalta, I; Ten, NS; Batista, VS; Loria, JP Characterization of Protein Tyrosine Phosphatase 1B Inhibition by Chlorogenic Acid and Cichoric Acid. Biochemistry 56: 96-106 (2017)
- Gambini, L; Baggio, C; Udompholkul, P; Jossart, J; Salem, AF; Perry, JJP; Pellecchia, M Covalent Inhibitors of Protein-Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues. J Med Chem 62: 5616-5627 (2019)
- Brown, K; Long, JM; Vial, SC; Dedi, N; Dunster, NJ; Renwick, SB; Tanner, AJ; Frantz, JD; Fleming, MA; Cheetham, GM Crystal structures of interleukin-2 tyrosine kinase and their implications for the design of selective inhibitors. J Biol Chem 279: 18727-32 (2004)
- Gu, X; Wang, Y; Kumar, A; Ye, G; Parang, K; Sun, G Design and evaluation of hydroxamate derivatives as metal-mediated inhibitors of a protein tyrosine kinase. J Med Chem 49: 7532-9 (2006)
- Yin, JP; Tang, CL; Gao, LX; Ma, WP; Li, JY; Li, Y; Li, J; Nan, FJ Design and synthesis of paracaseolide A analogues as selective protein tyrosine phosphatase 1B inhibitors. Org Biomol Chem 12: 3441-5 (2014)
- Cheng, XC; Wang, RL; Dong, ZK; Li, J; Li, YY; Li, RR Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold. Bioorg Med Chem 20: 5738-44 (2012)
- East, JE; Carter, KM; Kennedy, PC; Schulte, NA; Toews, ML; Lynch, KR; Macdonald, TL Development of a phosphatase-resistant, L-tyrosine derived LPA1/LPA3 dual antagonist. Medchemcomm 2: 325-330 (2011)
- Peach, ML; Tan, N; Choyke, SJ; Giubellino, A; Athauda, G; Burke, TR; Nicklaus, MC; Bottaro, DP Directed discovery of agents targeting the Met tyrosine kinase domain by virtual screening. J Med Chem 52: 943-51 (2009)
- Cywin, CL; Zhao, BP; McNeil, DW; Hrapchak, M; Prokopowicz, AS; Goldberg, DR; Morwick, TM; Gao, A; Jakes, S; Kashem, M; Magolda, RL; Soll, RM; Player, MR; Bobko, MA; Rinker, J; DesJarlais, RL; Winters, MP Discovery and SAR of novel Naphthyridines as potent inhibitors of spleen tyrosine kinase (SYK). Bioorg Med Chem Lett 13: 1415-8 (2003)
- Pei, Z; Li, X; Liu, G; Abad-Zapatero, C; Lubben, T; Zhang, T; Ballaron, SJ; Hutchins, CW; Trevillyan, JM; Jirousek, MR Discovery and SAR of novel, potent and selective protein tyrosine phosphatase 1B inhibitors. Bioorg Med Chem Lett 13: 3129-32 (2003)
- Liu, R; Liu, L; Liu, T; Yang, X; Wan, Y; Fang, H Discovery and development of substituted tyrosine derivatives as Bcl-2/Mcl-1 inhibitors. Bioorg Med Chem 26: 4907-4915 (2018)
- Schoepfer, J; Jahnke, W; Berellini, G; Buonamici, S; Cotesta, S; Cowan-Jacob, SW; Dodd, S; Drueckes, P; Fabbro, D; Gabriel, T; Groell, JM; Grotzfeld, RM; Hassan, AQ; Henry, C; Iyer, V; Jones, D; Lombardo, F; Loo, A; Manley, PW; Pellé, X; Rummel, G; Salem, B; Warmuth, M; Wylie, AA; Zoller, T; Marzinzik, AL; Furet, P Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1. J Med Chem 61: 8120-8135 (2018)
- Currie, KS; Kropf, JE; Lee, T; Blomgren, P; Xu, J; Zhao, Z; Gallion, S; Whitney, JA; Maclin, D; Lansdon, EB; Maciejewski, P; Rossi, AM; Rong, H; Macaluso, J; Barbosa, J; Di Paolo, JA; Mitchell, SA Discovery of GS-9973, a selective and orally efficacious inhibitor of spleen tyrosine kinase. J Med Chem 57: 3856-73 (2014)
- Tichenor, MS; Wiener, JJM; Rao, NL; Bacani, GM; Wei, J; Pooley Deckhut, C; Barbay, JK; Kreutter, KD; Chang, L; Clancy, KW; Murrey, HE; Wang, W; Ahn, K; Huber, M; Rex, E; Coe, KJ; Wu, J; Rui, H; Sepassi, K; Gaudiano, M; Bekkers, M; Cornelissen, I; Packman, K; Seierstad, M; Xiouras, C; Bembenek, SD; Alexander, R; Milligan, C; Balasubramanian, S; Lebsack, AD; Venable, JD; Philippar, U; Edwards, JP; Hirst, G Discovery of JNJ-64264681: A Potent and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase. J Med Chem 65: 14326-14336 (2022)
- Li, YQ; Lannigan, WG; Davoodi, S; Daryaee, F; Corrionero, A; Alfonso, P; Rodriguez-Santamaria, JA; Wang, N; Haley, JD; Tonge, PJ Discovery of Novel Bruton's Tyrosine Kinase PROTACs with Enhanced Selectivity and Cellular Efficacy. J Med Chem 66: 7454-7474 (2023)
- Owens, TD; Brameld, KA; Verner, EJ; Ton, T; Li, X; Zhu, J; Masjedizadeh, MR; Bradshaw, JM; Hill, RJ; Tam, D; Bisconte, A; Kim, EO; Francesco, M; Xing, Y; Shu, J; Karr, D; LaStant, J; Finkle, D; Loewenstein, N; Haberstock-Debic, H; Taylor, MJ; Nunn, P; Langrish, CL; Goldstein, DM Discovery of Reversible Covalent Bruton's Tyrosine Kinase Inhibitors PRN473 and PRN1008 (Rilzabrutinib). J Med Chem 65: 5300-5316 (2022)
- Dai, HL; Gao, LX; Yang, Y; Li, JY; Cheng, JG; Li, J; Wen, R; Peng, YQ; Zheng, JB Discovery of di-indolinone as a novel scaffold for protein tyrosine phosphatase 1B inhibitors. Bioorg Med Chem Lett 22: 7440-3 (2012)
- Li, S; Sun, X; Zhao, H; Tang, Y; Lan, M Discovery of novel EGFR tyrosine kinase inhibitors by structure-based virtual screening. Bioorg Med Chem Lett 22: 4004-9 (2012)
- Liu, J; Chen, C; Wang, D; Zhang, J; Zhang, T Emerging small-molecule inhibitors of the Bruton's tyrosine kinase (BTK): Current development. Eur J Med Chem 217: (2021)
- Yamazaki, H; Tsuge, H; Takahashi, O; Uchida, R Germacrane sesquiterpenes from leaves of Eupatorium chinense inhibit protein tyrosine phosphatase. Bioorg Med Chem Lett 53: (2021)
- Kiss, R; Polgár, T; Kirabo, A; Sayyah, J; Figueroa, NC; List, AF; Sokol, L; Zuckerman, KS; Gali, M; Bisht, KS; Sayeski, PP; Keseru, GM Identification of a novel inhibitor of JAK2 tyrosine kinase by structure-based virtual screening. Bioorg Med Chem Lett 19: 3598-601 (2009)
- Lee, HS; Ku, B; Park, TH; Park, H; Choi, JK; Chang, KT; Kim, CH; Ryu, SE; Kim, SJ Identification of novel protein tyrosine phosphatase sigma inhibitors promoting neurite extension. Bioorg Med Chem Lett 26: 87-93 (2016)
- Mitchell, SA; Danca, MD; Blomgren, PA; Darrow, JW; Currie, KS; Kropf, JE; Lee, SH; Gallion, SL; Xiong, JM; Pippin, DA; DeSimone, RW; Brittelli, DR; Eustice, DC; Bourret, A; Hill-Drzewi, M; Maciejewski, PM; Elkin, LL Imidazo[1,2-a]pyrazine diaryl ureas: inhibitors of the receptor tyrosine kinase EphB4. Bioorg Med Chem Lett 19: 6991-5 (2009)
- He, R; Wang, J; Yu, ZH; Zhang, RY; Liu, S; Wu, L; Zhang, ZY Inhibition of Low Molecular Weight Protein Tyrosine Phosphatase by an Induced-Fit Mechanism. J Med Chem 59: 9094-9106 (2016)
- Na, M; Oh, WK; Kim, YH; Cai, XF; Kim, S; Kim, BY; Ahn, JS Inhibition of protein tyrosine phosphatase 1B by diterpenoids isolated from Acanthopanax koreanum. Bioorg Med Chem Lett 16: 3061-4 (2006)
- Sun, SL; Wu, SH; Kang, JB; Ma, YY; Chen, L; Cao, P; Chang, L; Ding, N; Xue, X; Li, NG; Shi, ZH Medicinal Chemistry Strategies for the Development of Bruton's Tyrosine Kinase Inhibitors against Resistance. J Med Chem 65: 7415-7437 (2022)
- Wan, ZK; Lee, J; Xu, W; Erbe, DV; Joseph-McCarthy, D; Follows, BC; Zhang, YL Monocyclic thiophenes as protein tyrosine phosphatase 1B inhibitors: capturing interactions with Asp48. Bioorg Med Chem Lett 16: 4941-5 (2006)
- Czarna, A; Wang, J; Zelencova, D; Liu, Y; Deng, X; Choi, HG; Zhang, T; Zhou, W; Chang, JW; Kildalsen, H; Seternes, OM; Gray, NS; Engh, RA; Rothweiler, U Novel Scaffolds for Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase (DYRK1A) Inhibitors. J Med Chem 61: 7560-7572 (2018)
- Chen, CH; Lee, O; Yao, CN; Chuang, MY; Chang, YL; Chang, MH; Wen, YF; Yang, WH; Ko, CH; Chou, NT; Lin, MW; Lai, CP; Sun, CY; Wang, LM; Chen, YC; Hseu, TH; Chang, CN; Hsu, HC; Lin, HC; Chang, YL; Shih, YC; Chou, SH; Hsu, YL; Tseng, HW; Liu, CP; Tu, CM; Hu, TL; Tsai, YJ; Chen, TS; Lin, CL; Chiou, SJ; Liu, CC; Hwang, CS Novel azulene-based derivatives as potent multi-receptor tyrosine kinase inhibitors. Bioorg Med Chem Lett 20: 6129-32 (2010)
- Kotoris, CC; Chen, MJ; Taylor, SD Novel phosphate mimetics for the design of non-peptidyl inhibitors of protein tyrosine phosphatases. Bioorg Med Chem Lett 8: 3275-80 (1999)
- Li, S; Li, W; Wang, Y; Asada, Y; Koike, K Prenylflavonoids from Glycyrrhiza uralensis and their protein tyrosine phosphatase-1B inhibitory activities. Bioorg Med Chem Lett 20: 5398-401 (2010)
- Shi, Q; Tebben, A; Dyckman, AJ; Li, H; Liu, C; Lin, J; Spergel, S; Burke, JR; McIntyre, KW; Olini, GC; Strnad, J; Surti, N; Muckelbauer, JK; Chang, C; An, Y; Cheng, L; Ruan, Q; Leftheris, K; Carter, PH; Tino, J; De Lucca, GV Purine derivatives as potent Bruton's tyrosine kinase (BTK) inhibitors for autoimmune diseases. Bioorg Med Chem Lett 24: 2206-11 (2014)
- Zhao, X; Huang, W; Wang, Y; Xin, M; Jin, Q; Cai, J; Tang, F; Zhao, Y; Xiang, H Pyrrolo[2,3-b]pyridine derivatives as potent Bruton's tyrosine kinase inhibitors. Bioorg Med Chem 23: 4344-53 (2015)
- Teng, M; Ficarro, SB; Yoon, H; Che, J; Zhou, J; Fischer, ES; Marto, JA; Zhang, T; Gray, NS Rationally Designed Covalent BCL6 Inhibitor That Targets a Tyrosine Residue in the Homodimer Interface. ACS Med Chem Lett 11: 1269-1273 (2020)
- Wu, X; Xu, G; Li, X; Xu, W; Li, Q; Liu, W; Kirby, KA; Loh, ML; Li, J; Sarafianos, SG; Qu, CK Small Molecule Inhibitor that Stabilizes the Autoinhibited Conformation of the Oncogenic Tyrosine Phosphatase SHP2. J Med Chem 62: 1125-1137 (2019)
- Nguyen, TA; Ha, MT; Park, SE; Choi, JS; Min, BS; Kim, JA Stilbenes with Potent Protein Tyrosine Phosphatase-1B Inhibitory Activity from the Roots of J Nat Prod 83: 323-332 (2020)
- Blair, JA; Rauh, D; Kung, C; Yun, CH; Fan, QW; Rode, H; Zhang, C; Eck, MJ; Weiss, WA; Shokat, KM Structure-guided development of affinity probes for tyrosine kinases using chemical genetics. Nat Chem Biol 3: 229-38 (2007)
- Mohammadi, M; McMahon, G; Sun, L; Tang, C; Hirth, P; Yeh, BK; Hubbard, SR; Schlessinger, J Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. Science 276: 955-60 (1997)
- Chen, R Substituted imidazo[1,5-a]pyrazines as Bruton's tyrosine kinase inhibitors US Patent US11420975 (2022)
- Wang, Z; Guo, Y Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulators US Patent US9447106 (2016)
- Nakamura, H; Sasaki, Y; Uno, M; Yoshikawa, T; Asano, T; Ban, HS; Fukazawa, H; Shibuya, M; Uehara, Y Synthesis and biological evaluation of benzamides and benzamidines as selective inhibitors of VEGFR tyrosine kinases. Bioorg Med Chem Lett 16: 5127-31 (2006)
- Cushman, M; Nagarathnam, D; Gopal, D; Geahlen, RL Synthesis and evaluation of new protein-tyrosine kinase inhibitors. Part 2. Phenylhydrazones. Bioorg Med Chem Lett 1: 215-218 (1991)
- Thakkar, K; Geahlen, RL; Cushman, M Synthesis and protein-tyrosine kinase inhibitory activity of polyhydroxylated stilbene analogues of piceatannol. J Med Chem 36: 2950-5 (1993)
- Han, SY; Park, SS; Lee, WG; Min, YK; Kim, BT Synthesis of a novel biotin-tagged photoaffinity probe for VEGF receptor tyrosine kinases. Bioorg Med Chem Lett 16: 129-33 (2005)
- Saxena, AK; Pandey, G; Gupta, S; Singh, AB; Srivastava, AK Synthesis of protein tyrosine phosphatase 1B inhibitors: model validation and docking studies. Bioorg Med Chem Lett 19: 2320-3 (2009)
- Chiaradia, LD; Mascarello, A; Purificação, M; Vernal, J; Cordeiro, MN; Zenteno, ME; Villarino, A; Nunes, RJ; Yunes, RA; Terenzi, H Synthetic chalcones as efficient inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase PtpA. Bioorg Med Chem Lett 18: 6227-30 (2008)
- Sens, L; de Souza, ACA; Pacheco, LA; Menegatti, ACO; Mori, M; Mascarello, A; Nunes, RJ; Terenzi, H Synthetic thiosemicarbazones as a new class of Mycobacterium tuberculosis protein tyrosine phosphatase A inhibitors. Bioorg Med Chem 26: 5742-5750 (2018)
- Asami, T; Kawahata, W; Sawa, M TR-FRET binding assay targeting unactivated form of Bruton's tyrosine kinase. Bioorg Med Chem Lett 25: 2033-6 (2015)
- Tasker, NR; Rastelli, EJ; Burnett, JC; Sharlow, ER; Lazo, JS; Wipf, P Tapping the therapeutic potential of protein tyrosine phosphatase 4A with small molecule inhibitors. Bioorg Med Chem Lett 29: 2008-2015 (2019)
- Wang, X; Zhang, W; Frye, S Therapeutic uses of selected pyrimidine compounds with anti-Mer tyrosine kinase activity US Patent US9649309 (2017)
- Wang, X; Zhang, W; Frye, S Therapeutic uses of selected pyrrolopyrimidine compounds with anti-mer tyrosine kinase activity US Patent US10004755 (2018)
- Kansal, N; Silakari, O; Ravikumar, M Three dimensional pharmacophore modelling for c-Kit receptor tyrosine kinase inhibitors. Eur J Med Chem 45: 393-404 (2010)
- Jin, Q; Davis, RS; Bullion, AM; Jin, J; Wang, Y; Widdowson, KL; Palovich, MR; Foley, JJ; Schmidt, DB; Buckley, PT; Webb, EF; Salmon, M; Belmonte, KE; Sarau, HM; Busch-Petersen, J Tyrosine urea muscarinic acetylcholine receptor antagonists: achiral quaternary ammonium groups. Bioorg Med Chem Lett 22: 7087-91 (2012)
- Boschelli, DH; Wu, Z; Klutchko, SR; Showalter, HD; Hamby, JM; Lu, GH; Major, TC; Dahring, TK; Batley, B; Panek, RL; Keiser, J; Hartl, BG; Kraker, AJ; Klohs, WD; Roberts, BJ; Patmore, S; Elliott, WL; Steinkampf, R; Bradford, LA; Hallak, H; Doherty, AM Synthesis and tyrosine kinase inhibitory activity of a series of 2-amino-8H-pyrido[2,3-d]pyrimidines: identification of potent, selective platelet-derived growth factor receptor tyrosine kinase inhibitors. J Med Chem 41: 4365-77 (1998)
- Rewcastle, GW; Palmer, BD; Thompson, AW; Bridges, AJ; Cody, DR; Zhou, HR; Fry, DW; McMichael, A; Denny, WA Tyrosine Kinase Inhibitors. 10. Isomeric 4-[(3-Bromophenyl)amino]pyrido[d]- pyrimidines Are Potent ATP Binding Site Inhibitors of the Tyrosine Kinase Function of the Epidermal Growth Factor Receptor J Med Chem 39: 1823-35 (1996)
- Thompson, AM; Fry, DW; Kraker, AJ; Denny, WA Tyrosine kinase inhibitors. 2. Synthesis of 2,2'-dithiobis(1H-indole-3-alkanamides) and investigation of their inhibitory activity against epidermal growth factor receptor and pp60v-src protein tyrosine kinases. J Med Chem 37: 598-609 (1994)
- Rewcastle, GW; Palmer, BD; Dobrusin, EM; Fry, DW; Kraker, AJ; Denny, WA Tyrosine kinase inhibitors. 3. Structure-activity relationships for inhibition of protein tyrosine kinases by nuclear-substituted derivatives of 2,2'-dithiobis(1-methyl-N-phenyl-1H-indole-3-carboxamide). J Med Chem 37: 2033-42 (1994)
- Showalter, HD; Bridges, AJ; Zhou, H; Sercel, AD; McMichael, A; Fry, DW Tyrosine kinase inhibitors. 16. 6,5,6-tricyclic benzothieno[3, 2-d]pyrimidines and pyrimido[5,4-b-] and -[4,5-b]indoles as potent inhibitors of the epidermal growth factor receptor tyrosine kinase. J Med Chem 42: 5464-74 (1999)
- Dinges, J; Ashworth, KL; Akritopoulou-Zanze, I; Akritopolou-Zanze, I; Arnold, LD; Baumeister, SA; Bousquet, PF; Cunha, GA; Davidsen, SK; Djuric, SW; Gracias, VJ; Michaelides, MR; Rafferty, P; Sowin, TJ; Stewart, KD; Xia, Z; Zhang, HQ 1,4-Dihydroindeno[1,2-c]pyrazoles as novel multitargeted receptor tyrosine kinase inhibitors. Bioorg Med Chem Lett 16: 4266-71 (2006)
- Ji, Z; Ahmed, AA; Albert, DH; Bouska, JJ; Bousquet, PF; Cunha, GA; Diaz, G; Glaser, KB; Guo, J; Harris, CM; Li, J; Marcotte, PA; Moskey, MD; Oie, T; Pease, L; Soni, NB; Stewart, KD; Davidsen, SK; Michaelides, MR 3-Amino-benzo[d]isoxazoles as Novel Multitargeted Inhibitors of Receptor Tyrosine Kinases. J Med Chem 51: 1231-41 (2008)
- Maguire, MP; Sheets, KR; McVety, K; Spada, AP; Zilberstein, A A new series of PDGF receptor tyrosine kinase inhibitors: 3-substituted quinoline derivatives. J Med Chem 37: 2129-37 (1994)
- Marugan, JJ; Ferrer, M; Southall, NT; Dulcey, AE; Hu, X; Dextras, CR; Talley, DC; Alvarez, A; Zanlungo, S; Von Bernhardi, RM C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same US Patent US11649218 (2023)
- PubChem, PC Cdc25B Catalytic Domain Protein Tyrosine Phosphatase HTS Dose Response Confirmation Assay PubChem Bioassay (2006)
- Punthasee, P; Laciak, AR; Cummings, AH; Ruddraraju, KV; Lewis, SM; Hillebrand, R; Singh, H; Tanner, JJ; Gates, KS Covalent Allosteric Inactivation of Protein Tyrosine Phosphatase 1B (PTP1B) by an Inhibitor-Electrophile Conjugate. Biochemistry 56: 2051-2060 (2017)
- Xu, JQ; Shen, Q; Li, J; Hu, LH Dammaranes from Gynostemma pentaphyllum and synthesis of their derivatives as inhibitors of protein tyrosine phosphatase 1B. Bioorg Med Chem 18: 3934-9 (2010)
- Hou, F; Yao, Y; Wei, Y; Wang, Y; Cao, Y; Liu, X; Zheng, L; Zhang, Q; Jiao, Y; Chen, Y; Meng, Y; Sun, Y; Wu, Y; Wang, J; Wang, J; Wu, Z; Zhang, K; Wei, M; Yang, G Design and discovery of new selective and potent VEGF receptor 2 tyrosine kinase inhibitors. Bioorg Med Chem 91: (2023)
- Raeppel, SL; Therrien, E; Raeppel, F Design and synthesis of constrained analogs of LCRF-0004 as potent RON tyrosine kinase inhibitors. Bioorg Med Chem Lett 25: 3706-10 (2015)
- Pulz, R; Angst, D; Dawson, J; Gessier, F; Gutmann, S; Hersperger, R; Hinniger, A; Janser, P; Koch, G; Revesz, L; Vulpetti, A; Waelchli, R; Zimmerlin, A; Cenni, B Design of Potent and Selective Covalent Inhibitors of Bruton's Tyrosine Kinase Targeting an Inactive Conformation. ACS Med Chem Lett 10: 1467-1472 (2019)
- Liu, Z; Lee, W; Kim, SN; Yoon, G; Cheon, SH Design, synthesis, and evaluation of bromo-retrochalcone derivatives as protein tyrosine phosphatase 1B inhibitors. Bioorg Med Chem Lett 21: 3755-8 (2011)
- Lum, RT; Cheng, M; Cristobal, CP; Goldfine, ID; Evans, JL; Keck, JG; Macsata, RW; Manchem, VP; Matsumoto, Y; Park, SJ; Rao, SS; Robinson, L; Shi, S; Spevak, WR; Schow, SR Design, synthesis, and structure-activity relationships of novel insulin receptor tyrosine kinase activators. J Med Chem 51: 6173-87 (2008)
- Dreassi, E; Zizzari, AT; Falchi, F; Schenone, S; Santucci, A; Maga, G; Botta, M Determination of permeability and lipophilicity of pyrazolo-pyrimidine tyrosine kinase inhibitors and correlation with biological data. Eur J Med Chem 44: 3712-7 (2009)
- Vazquez, J; Tautz, L; Ryan, JJ; Vuori, K; Mustelin, T; Pellecchia, M Development of molecular probes for second-site screening and design of protein tyrosine phosphatase inhibitors. J Med Chem 50: 2137-43 (2007)
- Trinks, U; Buchdunger, E; Furet, P; Kump, W; Mett, H; Meyer, T; Müller, M; Regenass, U; Rihs, G; Lydon, N Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase. J Med Chem 37: 1015-27 (1994)
- Liu, G; Szczepankiewicz, BG; Pei, Z; Janowick, DA; Xin, Z; Hajduk, PJ; Abad-Zapatero, C; Liang, H; Hutchins, CW; Fesik, SW; Ballaron, SJ; Stashko, MA; Lubben, T; Mika, AK; Zinker, BA; Trevillyan, JM; Jirousek, MR Discovery and structure-activity relationship of oxalylarylaminobenzoic acids as inhibitors of protein tyrosine phosphatase 1B. J Med Chem 46: 2093-103 (2003)
- Kawahata, W; Asami, T; Kiyoi, T; Irie, T; Kashimoto, S; Furuichi, H; Sawa, M Discovery of AS-1763: A Potent, Selective, Noncovalent, and Orally Available Inhibitor of Bruton's Tyrosine Kinase. J Med Chem 64: 14129-14141 (2021)
- Liddle, J; Atkinson, FL; Barker, MD; Carter, PS; Curtis, NR; Davis, RP; Douault, C; Dickson, MC; Elwes, D; Garton, NS; Gray, M; Hayhow, TG; Hobbs, CI; Jones, E; Leach, S; Leavens, K; Lewis, HD; McCleary, S; Neu, M; Patel, VK; Preston, AG; Ramirez-Molina, C; Shipley, TJ; Skone, PA; Smithers, N; Somers, DO; Walker, AL; Watson, RJ; Weingarten, GG Discovery of GSK143, a highly potent, selective and orally efficacious spleen tyrosine kinase inhibitor. Bioorg Med Chem Lett 21: 6188-94 (2011)
- Angst, D; Gessier, F; Janser, P; Vulpetti, A; Wälchli, R; Beerli, C; Littlewood-Evans, A; Dawson, J; Nuesslein-Hildesheim, B; Wieczorek, G; Gutmann, S; Scheufler, C; Hinniger, A; Zimmerlin, A; Funhoff, EG; Pulz, R; Cenni, B Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton's Tyrosine Kinase. J Med Chem 63: 5102-5118 (2020)
- Taniguchi, T; Inagaki, H; Baba, D; Yasumatsu, I; Toyota, A; Kaneta, Y; Kiga, M; Iimura, S; Odagiri, T; Shibata, Y; Ueda, K; Seo, M; Shimizu, H; Imaoka, T; Nakayama, K Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors with Antitumor Activity. ACS Med Chem Lett 10: 737-742 (2019)
- Wang, X; Barbosa, J; Blomgren, P; Bremer, MC; Chen, J; Crawford, JJ; Deng, W; Dong, L; Eigenbrot, C; Gallion, S; Hau, J; Hu, H; Johnson, AR; Katewa, A; Kropf, JE; Lee, SH; Liu, L; Lubach, JW; Macaluso, J; Maciejewski, P; Mitchell, SA; Ortwine, DF; DiPaolo, J; Reif, K; Scheerens, H; Schmitt, A; Wong, H; Xiong, JM; Xu, J; Zhao, Z; Zhou, F; Currie, KS; Young, WB Discovery of Potent and Selective Tricyclic Inhibitors of Bruton's Tyrosine Kinase with Improved Druglike Properties. ACS Med Chem Lett 8: 608-613 (2017)
- Lam, B; Arikawa, Y; Cramlett, J; Dong, Q; de Jong, R; Feher, V; Grimshaw, CE; Farrell, PJ; Hoffman, ID; Jennings, A; Jones, B; Matuszkiewicz, J; Miura, J; Miyake, H; Natala, SR; Shi, L; Takahashi, M; Taylor, E; Wyrick, C; Yano, J; Zalevsky, J; Nie, Z Discovery of TAK-659 an orally available investigational inhibitor of Spleen Tyrosine Kinase (SYK). Bioorg Med Chem Lett 26: 5947-5950 (2016)
- Gerstenberger, BS; Ambler, C; Arnold, EP; Banker, ME; Brown, MF; Clark, JD; Dermenci, A; Dowty, ME; Fensome, A; Fish, S; Hayward, MM; Hegen, M; Hollingshead, BD; Knafels, JD; Lin, DW; Lin, TH; Owen, DR; Saiah, E; Sharma, R; Vajdos, FF; Xing, L; Yang, X; Yang, X; Wright, SW Discovery of Tyrosine Kinase 2 (TYK2) Inhibitor (PF-06826647) for the Treatment of Autoimmune Diseases. J Med Chem 63: 13561-13577 (2020)
- Sammond, DM; Nailor, KE; Veal, JM; Nolte, RT; Wang, L; Knick, VB; Rudolph, SK; Truesdale, AT; Nartey, EN; Stafford, JA; Kumar, R; Cheung, M Discovery of a novel and potent series of dianilinopyrimidineurea and urea isostere inhibitors of VEGFR2 tyrosine kinase. Bioorg Med Chem Lett 15: 3519-23 (2005)
- Zhao, H; Dong, J; Lafleur, K; Nevado, C; Caflisch, A Discovery of a novel chemotype of tyrosine kinase inhibitors by fragment-based docking and molecular dynamics. ACS Med Chem Lett 3: 834-838 (2012)
- Stanford, SM; Krishnamurthy, D; Falk, MD; Messina, R; Debnath, B; Li, S; Liu, T; Kazemi, R; Dahl, R; He, Y; Yu, X; Chan, AC; Zhang, ZY; Barrios, AM; Woods, VL; Neamati, N; Bottini, N Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells. J Med Chem 54: 1640-54 (2011)
- Wang, C; Wang, R; Chen, Y; Wang, L; Zhou, S; Wang, H Discovery of an EGFR tyrosine kinase inhibitor from Ilex latifolia in breast cancer therapy. Bioorg Med Chem Lett 29: 1282-1290 (2019)
- Plé, PA; Jung, F; Ashton, S; Hennequin, L; Laine, R; Lambert-van der Brempt, C; Morgentin, R; Pasquet, G; Taylor, S Discovery of new quinoline ether inhibitors with high affinity and selectivity for PDGFR tyrosine kinases. Bioorg Med Chem Lett 22: 3050-5 (2012)
- Jarhad, DB; Mashelkar, KK; Kim, HR; Noh, M; Jeong, LS Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics. J Med Chem 61: 9791-9810 (2018)
- Blanchard, JL; Epstein, DM; Boisclair, MD; Rudolph, J; Pal, K Dysidiolide and related gamma-hydroxy butenolide compounds as inhibitors of the protein tyrosine phosphatase, CDC25. Bioorg Med Chem Lett 9: 2537-8 (1999)
- Ban, HS; Tanaka, Y; Nabeyama, W; Hatori, M; Nakamura, H Enhancement of EGFR tyrosine kinase inhibition by C-C multiple bonds-containing anilinoquinazolines. Bioorg Med Chem 18: 870-9 (2010)
- van Linden, OP; Farenc, C; Zoutman, WH; Hameetman, L; Wijtmans, M; Leurs, R; Tensen, CP; Siegal, G; de Esch, IJ Fragment based lead discovery of small molecule inhibitors for the EPHA4 receptor tyrosine kinase. Eur J Med Chem 47: 493-500 (2012)
- Rawls, KA; Lang, PT; Takeuchi, J; Imamura, S; Baguley, TD; Grundner, C; Alber, T; Ellman, JA Fragment-based discovery of selective inhibitors of the Mycobacterium tuberculosis protein tyrosine phosphatase PtpA. Bioorg Med Chem Lett 19: 6851-4 (2009)
- Romagnoli, R; Baraldi, PG; Carrion, MD; Cara, CL; Preti, D; Cruz-Lopez, O; Tabrizi, MA; Moorman, AR; Gessi, S; Fogli, E; Sacchetto, V; Borea, PA From tyrosine to glycine: synthesis and biological activity of potent antagonists of the purinergic P2X7 receptor. J Med Chem 50: 3706-15 (2007)
- Yen, S; Liao, C; Wang, H; Chen, P; Pan, Y; Li, T; Chen, B; Chiou, S Heterocycle compounds as Tyro3, Axl and MerTK (TAM) family of receptor tyrosine kinase inhibitors US Patent US11407757 (2022)
- Jin, J; Ye, X; Boateng, D; Dai, K; Ye, F; Du, P; Yu, H Identification and characterization of potent and selective inhibitors targeting protein tyrosine phosphatase 1B (PTP1B). Bioorg Med Chem Lett 29: 2358-2363 (2019)
- Ge, L; Li, KS; Li, MM; Xiao, P; Hou, XB; Chen, X; Liu, HD; Lin, A; Yu, X; Ren, GJ; Fang, H; Sun, JP Identification of a benzo imidazole thiazole derivative as the specific irreversible inhibitor of protein tyrosine phosphatase. Bioorg Med Chem Lett 26: 4795-4798 (2016)
- Xin, Z; Liu, G; Abad-Zapatero, C; Pei, Z; Szczepankiewicz, BG; Li, X; Zhang, T; Hutchins, CW; Hajduk, PJ; Ballaron, SJ; Stashko, MA; Lubben, TH; Trevillyan, JM; Jirousek, MR Identification of a monoacid-based, cell permeable, selective inhibitor of protein tyrosine phosphatase 1B. Bioorg Med Chem Lett 13: 3947-50 (2003)
- Seiler, CL; Richards, KA; Jakubowski, HV; McIntee, EJ Identification of new inhibitors for low molecular weight protein tyrosine phosphatase isoform B. Bioorg Med Chem Lett 23: 5912-4 (2013)
- Zhou, LM; Kong, FD; Fan, P; Ma, QY; Xie, QY; Li, JH; Zheng, HZ; Zheng, ZH; Yuan, JZ; Dai, HF; Luo, DQ; Zhao, YX Indole-Diterpenoids with Protein Tyrosine Phosphatase Inhibitory Activities from the Marine-Derived Fungus J Nat Prod 82: 2638-2644 (2019)
- Wu, J; Lawrence, NJ; Sebti, SM; Lawrence, HR Inhibition of Shp2/PTPN11 protein tyrosine phosphatase by NSC-87877, NSC-117199 and their analogs US Patent US8987474 (2015)
- Hou, X; Sun, JP; Ge, L; Liang, X; Li, K; Zhang, Y; Fang, H Inhibition of striatal-enriched protein tyrosine phosphatase by targeting computationally revealed cryptic pockets. Eur J Med Chem 190: (2020)
- Maddry, JA; Kussner, C; Truss, JW; Niwas, S; White, EL; Kwong, CD Inhibition of the her2 tyrosine kinase and characterization of a hydrophobic site near the nucleotide binding domain Bioorg Med Chem Lett 7: 2109-2114 (1997)
- Ballard, P; Bradbury, RH; Harris, CS; Hennequin, LF; Hickinson, M; Kettle, JG; Kendrew, J; Klinowska, T; Ogilvie, DJ; Pearson, SE; Williams, EJ; Wilson, I Inhibitors of epidermal growth factor receptor tyrosine kinase: optimisation of potency and in vivo pharmacokinetics. Bioorg Med Chem Lett 16: 4908-12 (2006)
- Kaur, M; Singh, M; Silakari, O Inhibitors of switch kinase 'spleen tyrosine kinase' in inflammation and immune-mediated disorders: a review. Eur J Med Chem 67: 434-46 (2013)
- Barlaam, B; Ducray, R; Lambert-van der Brempt, C; Plé, P; Bardelle, C; Brooks, N; Coleman, T; Cross, D; Kettle, JG; Read, J Inhibitors of the tyrosine kinase EphB4. Part 4: Discovery and optimization of a benzylic alcohol series. Bioorg Med Chem Lett 21: 2207-11 (2011)
- Na, M; Hoang, DM; Njamen, D; Mbafor, JT; Fomum, ZT; Thuong, PT; Ahn, JS; Oh, WK Inhibitory effect of 2-arylbenzofurans from Erythrina addisoniae on protein tyrosine phosphatase-1B. Bioorg Med Chem Lett 17: 3868-71 (2007)
- Yoon, G; Lee, W; Kim, SN; Cheon, SH Inhibitory effect of chalcones and their derivatives from Glycyrrhiza inflata on protein tyrosine phosphatase 1B. Bioorg Med Chem Lett 19: 5155-7 (2009)
- Tang, K; Jia, YN; Yu, B; Liu, HM Medicinal chemistry strategies for the development of protein tyrosine phosphatase SHP2 inhibitors and PROTAC degraders. Eur J Med Chem 204: (2020)
- Doman, TN; McGovern, SL; Witherbee, BJ; Kasten, TP; Kurumbail, R; Stallings, WC; Connolly, DT; Shoichet, BK Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B. J Med Chem 45: 2213-21 (2002)
- Nguyen, PH; Dao, TT; Kim, J; Phong, do T; Ndinteh, DT; Mbafor, JT; Oh, WK New 5-deoxyflavonoids and their inhibitory effects on protein tyrosine phosphatase 1B (PTP1B) activity. Bioorg Med Chem 19: 3378-83 (2011)
- Wang, Y; Shakespeare, WC; Huang, WS; Sundaramoorthi, R; Lentini, S; Das, S; Liu, S; Banda, G; Wen, D; Zhu, X; Xu, Q; Keats, J; Wang, F; Wardwell, S; Ning, Y; Snodgrass, JT; Broudy, MI; Russian, K; Dalgarno, D; Clackson, T; Sawyer, TK Novel N9-arenethenyl purines as potent dual Src/Abl tyrosine kinase inhibitors. Bioorg Med Chem Lett 18: 4907-12 (2008)
- Malamas, MS; Sredy, J; Moxham, C; Katz, A; Xu, W; McDevitt, R; Adebayo, FO; Sawicki, DR; Seestaller, L; Sullivan, D; Taylor, JR Novel benzofuran and benzothiophene biphenyls as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties. J Med Chem 43: 1293-310 (2001)
- Qin, X; Lv, Y; Liu, P; Li, Z; Hu, L; Zeng, C; Yang, L Novel morpholin-3-one fused quinazoline derivatives as EGFR tyrosine kinase inhibitors. Bioorg Med Chem Lett 26: 1571-5 (2016)
- Ellis, JM; Altman, MD; Bass, A; Butcher, JW; Byford, AJ; Donofrio, A; Galloway, S; Haidle, AM; Jewell, J; Kelly, N; Leccese, EK; Lee, S; Maddess, M; Miller, JR; Moy, LY; Osimboni, E; Otte, RD; Reddy, MV; Spencer, K; Sun, B; Vincent, SH; Ward, GJ; Woo, GH; Yang, C; Houshyar, H; Northrup, AB Overcoming mutagenicity and ion channel activity: optimization of selective spleen tyrosine kinase inhibitors. J Med Chem 58: 1929-39 (2015)
- Na, M; Cui, L; Min, BS; Bae, K; Yoo, JK; Kim, BY; Oh, WK; Ahn, JS Protein tyrosine phosphatase 1B inhibitory activity of triterpenes isolated from Astilbe koreana. Bioorg Med Chem Lett 16: 3273-6 (2006)
- Conconi, MT; Marzaro, G; Urbani, L; Zanusso, I; Di Liddo, R; Castagliuolo, I; Brun, P; Tonus, F; Ferrarese, A; Guiotto, A; Chilin, A Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties. Eur J Med Chem 67: 373-83 (2013)
- Panchal, RG; Ulrich, RL; Bradfute, SB; Lane, D; Ruthel, G; Kenny, TA; Iversen, PL; Anderson, AO; Gussio, R; Raschke, WC; Bavari, S Reduced expression of CD45 protein-tyrosine phosphatase provides protection against anthrax pathogenesis. J Biol Chem 284: 12874-85 (2009)
- Balboni, G; Marzola, E; Sasaki, Y; Ambo, A; Marczak, ED; Lazarus, LH; Salvadori, S Role of 2',6'-dimethyl-l-tyrosine (Dmt) in some opioid lead compounds. Bioorg Med Chem 18: 6024-30 (2010)
- Büttner, A; Cottin, T; Xu, J; Tzagkaroulaki, L; Giannis, A Serotonin derivatives as a new class of non-ATP-competitive receptor tyrosine kinase inhibitors. Bioorg Med Chem 18: 3387-402 (2010)
- Scott, LM; Chen, L; Daniel, KG; Brooks, WH; Guida, WC; Lawrence, HR; Sebti, SM; Lawrence, NJ; Wu, J Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs. Bioorg Med Chem Lett 21: 730-3 (2011)
- Ala, PJ; Gonneville, L; Hillman, MC; Becker-Pasha, M; Wei, M; Reid, BG; Klabe, R; Yue, EW; Wayland, B; Douty, B; Polam, P; Wasserman, Z; Bower, M; Combs, AP; Burn, TC; Hollis, GF; Wynn, R Structural basis for inhibition of protein-tyrosine phosphatase 1B by isothiazolidinone heterocyclic phosphonate mimetics. J Biol Chem 281: 32784-95 (2006)
- Ala, PJ; Gonneville, L; Hillman, M; Becker-Pasha, M; Yue, EW; Douty, B; Wayland, B; Polam, P; Crawley, ML; McLaughlin, E; Sparks, RB; Glass, B; Takvorian, A; Combs, AP; Burn, TC; Hollis, GF; Wynn, R Structural insights into the design of nonpeptidic isothiazolidinone-containing inhibitors of protein-tyrosine phosphatase 1B. J Biol Chem 281: 38013-21 (2006)
- Jia, Z; Ye, Q; Dinaut, AN; Wang, Q; Waddleton, D; Payette, P; Ramachandran, C; Kennedy, B; Hum, G; Taylor, SD Structure of protein tyrosine phosphatase 1B in complex with inhibitors bearing two phosphotyrosine mimetics. J Med Chem 44: 4584-94 (2001)
- Wang, Z; Guo, Y Substituted imidazo[1,2-b]pyrazoles as bruton'S tyrosine kinase modulators US Patent US9556188 (2017)
- Traxler, PM; Wacker, O; Bach, HL; Geissler, JF; Kump, W; Meyer, T; Regenass, U; Roesel, JL; Lydon, N Sulfonylbenzoyl-nitrostyrenes: potential bisubstrate type inhibitors of the EGF-receptor tyrosine protein kinase. J Med Chem 34: 2328-37 (1991)
- Liu, KG; Lambert, MH; Ayscue, AH; Henke, BR; Leesnitzer, LM; Oliver, WR; Plunket, KD; Xu, HE; Sternbach, DD; Willson, TM Synthesis and biological activity of L-tyrosine-based PPARgamma agonists with reduced molecular weight. Bioorg Med Chem Lett 11: 3111-3 (2001)
- Qian, S; Li, H; Chen, Y; Zhang, W; Yang, S; Wu, Y Synthesis and biological evaluation of oleanolic acid derivatives as inhibitors of protein tyrosine phosphatase 1B. J Nat Prod 73: 1743-50 (2010)
- Tang, PC; Feng, J; Huang, L; Xu, Z; Cheng, L; Zhang, X; Zhang, L; Hu, B Synthesis and biological evaluation of pyrrolopyridazine derivatives as novel HER-2 tyrosine kinase inhibitors. Bioorg Med Chem Lett 19: 6437-40 (2009)
- Sun, LP; Ma, WP; Gao, LX; Yang, LL; Quan, YC; Li, J; Piao, HR Synthesis and characterization of 5,7-dihydroxyflavanone derivatives as novel protein tyrosine phosphatase 1B inhibitors. J Enzyme Inhib Med Chem 28: 1199-204 (2013)
- Kruse, CH; Holden, KG; Pritchard, ML; Feild, JA; Rieman, DJ; Greig, RG; Poste, G Synthesis and evaluation of multisubstrate inhibitors of an oncogene-encoded tyrosine-specific protein kinase. 1. J Med Chem 31: 1762-7 (1988)
- Kruse, CH; Holden, KG; Offen, PH; Pritchard, ML; Feild, JA; Rieman, DJ; Bender, PE; Ferguson, B; Greig, RG; Poste, G Synthesis and evaluation of multisubstrate inhibitors of an oncogene-encoded tyrosine-specific protein kinase. 2. J Med Chem 31: 1768-72 (1988)
- Liu, Q; Guo, T; Li, D; Li, F; Li, W Synthesis and evaluation of several oleanolic acid glycoconjugates as protein tyrosine phosphatase 1B inhibitors. Eur J Med Chem 79: 34-46 (2014)
- Lee, GE; Joshi, BV; Chen, W; Jeong, LS; Moon, HR; Jacobson, KA; Kim, YC Synthesis and structure-activity relationship studies of tyrosine-based antagonists at the human P2X7 receptor. Bioorg Med Chem Lett 18: 571-5 (2008)
- Honda, T; Terao, T; Aono, H; Ban, M Synthesis of novel 1,4-benzoxazin-3-one derivatives as inhibitors against tyrosine kinases. Bioorg Med Chem 17: 699-708 (2009)
- Lü, S; Zheng, W; Ji, L; Luo, Q; Hao, X; Li, X; Wang, F Synthesis, characterization, screening and docking analysis of 4-anilinoquinazoline derivatives as tyrosine kinase inhibitors. Eur J Med Chem 61: 84-94 (2013)
- Martins, PG; Menegatti, AC; Chiaradia-Delatorre, LD; de Oliveira, KN; Guido, RV; Andricopulo, AD; Vernal, J; Yunes, RA; Nunes, RJ; Terenzi, H Synthetic chalcones and sulfonamides as new classes of Yersinia enterocolitica YopH tyrosine phosphatase inhibitors. Eur J Med Chem 64: 35-41 (2013)
- Chapelat, J; Berst, F; Marzinzik, AL; Moebitz, H; Drueckes, P; Trappe, J; Fabbro, D; Seebach, D The Substrate-Activity-Screening methodology applied to receptor tyrosine kinases: a proof-of-concept study. Eur J Med Chem 57: 1-9 (2012)
- Liang, C; Tian, D; Ren, X; Ding, S; Jia, M; Xin, M; Thareja, S The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review. Eur J Med Chem 151: 315-326 (2018)
- Allen, JV; Bardelle, C; Blades, K; Buttar, D; Chapman, L; Colclough, N; Dossetter, AG; Garner, AP; Girdwood, A; Lambert, C; Leach, AG; Law, B; Major, J; Plant, H; Slater, AM The discovery of benzanilides as c-Met receptor tyrosine kinase inhibitors by a directed screening approach. Bioorg Med Chem Lett 21: 5224-9 (2011)
- Geissler, JF; Traxler, P; Regenass, U; Murray, BJ; Roesel, JL; Meyer, T; McGlynn, E; Storni, A; Lydon, NB Thiazolidine-diones. Biochemical and biological activity of a novel class of tyrosine protein kinase inhibitors. J Biol Chem 265: 22255-61 (1990)
- Arabaci, G; Yi, T; Fu, H; Porter, ME; Beebe, KD; Pei, D alpha-bromoacetophenone derivatives as neutral protein tyrosine phosphatase inhibitors: structure-Activity relationship. Bioorg Med Chem Lett 12: 3047-50 (2002)
- Thompson, AM; Murray, DK; Elliott, WL; Fry, DW; Nelson, JA; Showalter, HD; Roberts, BJ; Vincent, PW; Denny, WA Tyrosine kinase inhibitors. 13. Structure-activity relationships for soluble 7-substituted 4-[(3-bromophenyl)amino]pyrido[4,3-d]pyrimidines designed as inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor. J Med Chem 40: 3915-25 (1997)
- Showalter, HD; Sercel, AD; Leja, BM; Wolfangel, CD; Ambroso, LA; Elliott, WL; Fry, DW; Kraker, AJ; Howard, CT; Lu, GH; Moore, CW; Nelson, JM; Roberts, BJ; Vincent, PW; Denny, WA; Thompson, AM Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners. J Med Chem 40: 413-26 (1997)
- Thompson, AM; Bridges, AJ; Fry, DW; Kraker, AJ; Denny, WA Tyrosine kinase inhibitors. 7. 7-Amino-4-(phenylamino)- and 7-amino-4-[(phenylmethyl)amino]pyrido[4,3-d]pyrimidines: a new class of inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor. J Med Chem 38: 3780-8 (1995)